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ABSTRACT
In May 2014, the Georgia General Assembly enacted
legislation establishing the Alzheimers Disease Registry
(Registry) in order to generate new data for research and policy
planning.1 The Georgia Alzheimers and Related Dementias
State Plan Task Force (Task Force) bill followed similar federal
legislation.2 This state action has not only drawn tremendous
attention to the continued prevalence of Alzheimers disease
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1. H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014) (There is
established within the Department of Public Health the Alzheimers Disease
Registry. The purpose of the registry shall be to assist in the development of
public policy and . . . shall provide a central data base of individuals with
Alzheimers disease or related disorders.); GA. CODE ANN. § 31-2A-17 (2015).
2. Laura Raines, State Task Force Addressing Major Aging Issues,
ATLANTA J. CONST. (Oct. 21, 2013), http://www.ajc.com/news/business/statetask-force-addressing-major-aging-issues/nbTLN/ (Georgias task force was
influenced by the National Alzheimers Project Act in 2011.).
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among the population of Georgia but also raised a series of
questions regarding the practicability, legality, and effectiveness
of the Registry.3 The lessons learned in Georgia, as the Registry
implementation moves forward, will provide guidance for other
states interested in collecting similar data. In Section I of this
article, we describe the legislative history and operation of the
Registry. In Section II, we compare the two other populationbased Alzheimers disease registries in the United States. In
Section III, we identify legal and ethical problems that may
arise as the Registry becomes fully operational. In Section IV,
we identify specific concerns regarding the data collection and
other procedural rules of the Registry. Finally, in Section V, we
articulate best practices for the Georgia Registry, considering
both the unique circumstances of the state as well as
generalizable concerns for other states.
I. Georgia Alzheimers Disease Registry.................................. 226
A. State Initiative Against Alzheimers Disease ........ 226
B. Scope And Objective Of The Georgia Registry ...... 230
C. Stakeholders Efforts To Establish Registry.......... 231
II. Other Comprehensive Population-Based Alzheimers
Disease Registries In U.S. ................................................... 234
A. South Carolina ......................................................... 235
B. West Virginia ........................................................... 237
C. Georgia Features And Lessons Learned................. 239
III. Legal And Ethical Concerns Of The Registry ................... 242
A. Constitutionality Of The Registry........................... 243
B. Georgia Constitutional Right To Privacy................ 246
C. The Health Insurance Portability And
Accountability Act.................................................... 250
D. Privacy Risks Despite Statutory Confidentiality
Requirement............................................................. 257
E. Adverse Effect On Physician-Patient
Relationship... .......................................................... 259
IV. Procedural Rules................................................................. 261
3. See, e.g., Memorandum from Toni Miles, MD, Institute of Gerontology,
University of Georgia and Organizer of the North Georgia/UGA Sponsored
Stakeholders Meeting to Brenda Fitzgerald, MD, State Health Commissioner,
Georgia Department of Public Health (June 18, 2014) (on file with author)
[hereinafter Sponsored Stakeholders Meeting Memorandum] (discussing the
scope of the Registry in terms of data collection methods, data access, and
data usage). An extensive review of the Stakeholders Meeting is discussed
infra Part I.C.
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INTRODUCTION
This article will recommend best practices for establishing
a comprehensive population-based Alzheimers disease registry
(the Registry) in Georgia.4 We anticipate that Georgia is
leading a nationwide trend in addressing the rapidly rising
incidence of Alzheimers disease and related dementia within
the aging population.5 Accordingly, our recommendations will

4. There are two main types of Alzheimers disease registries: hospitalbased and population-based. See generally N.Y. Dept of Health, Chronic
Disease Teaching Tools  Disease Registries, HEALTH.NY.GOV (Apr. 1999),
https://www.health.ny.gov/diseases/chronic/diseaser.htm (explaining hospitalbased and disease-based disease registries). Population-based Alzheimers
disease registries seek to collect data on all new cases of Alzheimers disease
occurring in a well-defined population. See generally id. Usually, the
population is the residents in a particular geographical region. Id. As a result,
the main objective of this type of Alzheimers disease registry is to produce
statistics on the occurrence of Alzheimers disease in a defined population and
to provide a framework for assessing and controlling the impact of Alzheimers
disease in the community. Thus, the emphasis is on epidemiology and public
health. See also SEER Training Modules, Population-Based Registries, NATL
CANCER
INST.,
http://training.seer.cancer.gov
/registration/types/population.html (last visited Sept. 13, 2015) (In
comparison to the hospital-based cancer registry, the data collected by the
population-based registry serves a wider range of purposes.).
5. See generally ALZHEIMERS ASSN, 2014 ALZHEIMERS DISEASE: FACTS
AND FIGURES 23 (2014), http://www.alz.org/downloads/Facts_Figures_2014.pdf
(predicting that [l]onger life expectancies and aging baby boomers will
increase the oldest-old, which are the individuals at the highest risk for
developing Alzheimers.).
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be valuable not only for Georgia but also for other states that
may establish similar databases in the future.6
Alzheimers disease destroys brain cells and affects
memory, thinking, and behavior.7 The Centers for Disease
Control and Prevention (CDC) estimates that Alzheimers
disease is perhaps the most common form of dementia8 and
the Alzheimers Association estimates it constitutes between
sixty and eighty percent of dementia cases.9 The disease is the
sixth-leading cause of death in the United States10 and costs
more than $200 billion in annual health care costs.11 As of
2014, there are nearly 130,000 Georgians suffering from
Alzheimers disease, and that number is expected to rise to
190,000 by the year 2025.12 As the Baby Boomer generation
ages and medical advances extend life expectancy, the
prevalence of Alzheimers disease will continue to grow.13
According to the report released in 2011 by Alzheimers Disease
International, a global patient advocacy organization, thirty-six
million people worldwide have Alzheimers disease or other
dementias, and as many as twenty-eight million may have not
been diagnosed.14 In fact, CDC research indicates that over

6. Although the Registry is called an Alzheimers Disease Registry, it
tracks both patients with Alzheimers disease and related dementias. See GA.
CODE ANN. § 31-2A-17 (2015) (The registry shall provide a central data base
of individuals with Alzheimers disease or related disorders. (emphasis
added)).
7. See What is Alzheimers?, ALZHEIMERS ASSN, http://www.alz.org
/alzheimers_disease_what_is_alzheimers.asp (last visited Feb. 25, 2015) (As
damage spreads, cells lose their ability to do their jobs and, eventually die,
causing irreversible damage in the brain.).
8. Mental Health: Dementia/Alzheimers Disease, CTRS. FOR DISEASE
CONTROL & PREVENTION (Oct. 4, 2013), http://www.cdc.gov/mentalhealth
/basics/mental-illness/dementia.htm.
9. 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at 6
tbl.1 (stating that Alzheimers is the [m]ost common type of dementia;
account[ing] for an estimated 60 percent to 80 percent of cases).
10. Id. at 25 (citing Sherry L. Murphy et al., Deaths: Final Data for 2010,
61:4 NATL CTR. FOR HEALTH STATISTICS 1 (2013), http://www.cdc.gov/nchs
/data/nvsr/nvsr61/nvsr61_04.pdf).
11. Id. at 43 (Total payments in 2014 (in 2014 dollars) for all individuals
with Alzheimers disease and other dementias are estimated at $214 billion.).
12. Id. at 22 tbl.2.
13. Id. at 23.
14. ALZHEIMERS DISEASE INTL, WORLD ALZHEIMER REPORT 2011: THE
BENEFITS OF EARLY DIAGNOSIS AND INTERVENTION 65 (2011),
http://www.alz.co.uk/research/WorldAlzheimerReport2011.pdf.
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fourteen percent of Georgians ages sixty or older report that
they have been increasingly experiencing confusion or memory
loss.15
In response to such widely shared concerns about
Alzheimers disease, on March 20, 2014, the Georgia General
Assembly passed House Bill 966,16 creating a statewide
comprehensive population-based Alzheimers disease registry
that will be housed within the Georgia Department of Public
Health.17 The Georgia bill was signed by Governor Nathan
Deal on April 29, 2014 and enacted into law on July 1, 2014.18
The bill follows a national trend, exemplified in President
Obamas Administrations comprehensive plan to fight
Alzheimers disease. The national Alzheimers plan aims to
enhance research to more effectively treat and cure Alzheimers
disease, increase efficiency and quality of care, support patients
and their families, augment public awareness of Alzheimers
disease, and improve data collection.19
Senator Renee Unterman, Chair of the Senate Health and
Human Services Committee, who sponsored Georgias
legislation, has been enthusiastic about the new Registry.20
15. See Walter C. Jones, CDC Research: 14% of Georgians Suffer Memory
Problems, ATHENS BANNER-HERALD (May 24, 2013), http://onlineathens.com
/health/2013-05-24/cdc-research-14-georgians-suffer-memory-problems (citing
the CDCs Georgia Behavioral Risk Factor Surveillance Systems Cognitive
Impairment Report: [o]ne in seven Georgians over age 60 reports worsening
memory problems.).
16. H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014).
17. See id. at § 1, art. 9 (There is established within the Department of
Public Health the Alzheimers Disease Registry.).
18. 2014 Bills Signed, OFFICE OF THE GOVERNOR, https://gov.georgia.gov
/bills-signed/2014 (last visited Oct. 1, 2015); see also GA. CODE ANN. § 31-2A17 (2015); H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014).
19. U.S. DEPT OF HEALTH & HUMAN SERVS.: NATL INST. ON AGING,
OBAMA ADMINISTRATION PRESENTS NATIONAL PLAN TO FIGHT ALZHEIMERS
DISEASE (May 15, 2012), http://www.nia.nih.gov/newsroom/2012/05/obamaadministration-presents-national-plan-fight-alzheimers-disease. Compare id.
(summarizing the national Alzheimers disease plan), with H.R. 966, 152d
Gen. Assemb., Reg. Sess. (Ga. 2014) (enacting the Georgia Alzheimers Disease
Registry).
20. Jeff Breedlove, Georgia State Senate: Senate Bill Creates Alzheimers
Disease Registry, GAPUNDIT, http://gapundit.com/2014/02/03/georgia-statesenate-senate-bill-creates-alzheimers-disease-registry/.
Renee
Unterman
started two senior citizen-based nonprofits: Friends of Gwinnett County
Senior Services and Aid Gwinnett. SENATE PRESS OFFICE, SENATOR RENEE
UNTERMAN
(Jan.
2013),
http://www.senate.ga.gov/senators
/Documents/PrintBios/BioUntermanRenee53.pdf. Senator Unterman is both a
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Despite strong support, there is concern that the Registry
invades patients personal privacy and could compromise
physicians ethical duties to their patients.21 Also, because a
disproportionate number of people diagnosed with Alzheimers
disease, both nationally and in Georgia, are ethnic minorities,22
the Registry should be especially attuned to the special needs
of those particular groups. By closer consideration of those and
other concerns, this article will recommend best practices for
Georgia and other states considering similar registries.
I. GEORGIA ALZHEIMERS DISEASE REGISTRY
A. STATE INITIATIVE AGAINST ALZHEIMERS DISEASE
Georgia has experienced an exponential increase of people
who are diagnosed with Alzheimers disease. In the next ten
years, incidence of Alzheimers disease in Georgia is projected
to increase by 46.2%.23 One factor explaining the rise may be
Georgias increasing popularity as a retirement destination.24
Alzheimers disease is a disease that almost exclusively affects
the older population.25 This growing trend will continue to
financially burden the state and its taxpayers.26 The national
trained nurse and a trained social worker, and she has been twice named
Public Health Hero by the Georgia Public Health Association. Id. She has
also been a regular contributor to Aging Services of Georgia. Id.
21. See NATL CTR. BIOTECHNOLOGY INFO., REGISTRIES FOR EVALUATING
PATIENT OUTCOMES ch. 7 (Richard E. Gliklich et al. eds., 3d ed. 2014),
http://www.ncbi.nlm.nih.gov/books/NBK208620/ (recognizing that there are
[c]oncerns about potential risks to individual privacy).
22. See Cynthia Post, Clinical Trial Tries To Shed Light On Impact Of
DAILY,
Genetics
On
Alzheimers
Disease,
ATLANTA
http://www.dnafiles.org/?q=outreach/ethnic-media-fellows/atlanta-ga-cynthiapost (last visited Feb. 25, 2015) (Current research shows Alzheimers disease
is more prevalent among African-Americans than among whites . . . .).
23. 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at 22.
24. See Emily Brandon, 10 Fast-Growing Retirement Spots, U.S. NEWS:
MONEY
(July
5,
2011),
http://money.usnews.com/money
/retirement/articles/2011/07/05/10-fast-growing-retirement-spots (stating that
Atlanta, Sandy Springs, and Marietta grew forty-four percent in population of
people ages sixty-five and older between 2000 and 2010).
25. See 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at
16 ([A]n estimated 5 million people age 65 and older and approximately
200,000 individuals under age 65 who have younger-onset Alzheimers.
(internal footnote omitted)).
26. S. 14, 152d Gen. Assemb., Reg. Sess. §1, art. 9 (Ga. 2013) (The
General Assembly further finds that access to quality health care for
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per patient lifetime cost for Alzheimers Disease care is
currently estimated at $175,000.27 With approximately
130,000 Georgians currently estimated to be diagnosed with
Alzheimers disease, the states cost over the lifetime of all
individuals suffering from the disease is estimated to exceed
twenty billion dollars.28 Since Georgia is projected to have
190,000 Alzheimers patients in 2025,29 the economic impact of
the disease could exceed thirty billion dollars.30 That
staggering figure does not even account for the economic
impact on unpaid caregivers, who, on a national scale, provide
billions of hours of services, not reflected in these cost
estimates.31 Those caregivers frequently suffer from their own
medical issues as a result of the stress and frequently must
take time off of work or retire early, which causes further
economic impact.32
More information is needed to effectively address the
increase of Alzheimers disease across the population.33 It is
extremely difficult to count accurately even the number of
current caseslet alone as-yet undiagnosed casesto project

Alzheimers and related dementias and the rising cost of such care are vitally
important to the citizens of Georgia.).
27. See Blanchette Rockefeller Neurosciences Inst., West Virginia
Alzheimers Disease Registry, W. VA. UNIV., http://www.wvadr.hsc.wvu.edu
(last visited Sept. 13, 2015).
28. See 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at
22 (projecting the number of Georgia citizens who are afflicted with
Alzheimers).
29. Id. at 22.
30. Id.; see also ALZHEIMERS ASSN, CHANGING THE TRAJECTORY OF
ALZHEIMERS DISEASE: HOW A TREATMENT BY 2025 SAVES LIVES AND DOLLARS
6 (2015), http://www.alz.org/documents_custom/trajectory.pdf (Medicaid costs
will increase about 330 percent . . . to $176 Billion in 2050.).
31. 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at 33
(Unpaid caregivers in each of the four most populous states . . . provided care
valued at more than $14 billion.).
32. Id. at 34 ([T]he care required of family members can result
in . . . health impairments, [and] lost wages due to disruptions in employment
and depleted income and finances.).
33. E.g. Preventing Alzheimers Disease: What Do We Know?, NATL INST.
ON
AGING,
https://www.nia.nih.gov/alzheimers/publication/preventingalzheimers-disease/search-alzheimers-prevention-strategies (last updated Feb.
13, 2015) (Observational studies have associated factors such as physical
activity, blood pressure, and diabetes control with changes in risk. More
research is needed to determine whether these factors can in fact directly help
prevent Alzheimers or cognitive decline.).
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future growth.34 The influx of retirees to Georgia will make
projections especially difficult.35 The Registry will provide
clearer data regarding the impact of Alzheimers disease and
related dementias on the state of Georgia, information that
may be used for research, policy planning, and treatment
purposes.36
Against this background, in 2013, the Georgia General
Assembly passed Senate Bill 14, creating the Georgia
Alzheimers and Related Dementias State Plan Task Force
(Task Force).37 This bill resulted from a joint effort of the
[Georgia] Department of Human Services, the Division of Aging
Services and the [Georgia] Department of Health.38 The Task
Force was greatly influenced by a federal statute, the National
Alzheimers Project Act of 2011, which required the U.S.
Department of Health and Human Services to create a plan,
coordinate research, and improve the care and treatment of
Alzheimers disease.39 Nationwide, more than forty states,
including Georgia, are developing state plans consistent with

34. See Raines, supra note 2 (quoting Dr. Toni P. Miles: [c]ounting the
number of people with Alzheimers and projecting how it will grow isnt as
easy as it sounds.).
35. Id. (quoting Dr. Toni P. Miles: Georgia has special issue in that it is a
retirement destination, so we arent sure how rapidly the elderly population is
going to grow.).
36. See Population-Based Registries, supra note 4 (Data from populationbased registries can be used for monitoring the distribution of late-diagnosed
cases of cancer of the types for which early diagnosis is the strategy for
control.).
37. See GA. CODE ANN. § 31-8-300 (2013) (repealed 2014); see also S. 14,
152d Gen. Assemb., Reg. Sess. (Ga. 2013). This bill was repealed, effective
April 29, 2014. S. 340, 152d Gen. Assemb., Reg. Sess. § 31 (Ga. 2013). The
Task Force was abolished, but an Advisory Council with the same
membership was created to review progress of the State Plan and make
recommendations for changes if warranted. GA. CODE ANN. § 31-8-305 (2013)
(repealed 2014).
38. See Raines, supra note 2 (citing Dr. Toni P. Miles).
39. See id. (quoting Dr. Toni P. Miles); see also OBAMA ADMINISTRATION
PRESENTS NATIONAL PLAN TO FIGHT ALZHEIMERS DISEASE, supra note 19
(discussing the federal governments national plan to fight Alzheimers
disease).
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the goals of the National Alzheimers Project.40 Georgia is one
of the first states to establish a Registry.41
Georgias Senate Bill 14 included formal recognition by the
General Assembly of the gravity of Alzheimers disease
throughout the nation.42 It also recognized the importance of
assessing the strengths and weaknesses of Georgias ability to
provide essential services and programs to patients with
Alzheimers disease and other dementias.43 Finally, it noted the
importance of leveraging resources from the private, public,
and non-profit sectors (including faith-based) to improve the
states ability to combat all forms of dementia.44
On June 23, 2014, the Advisory Council released a state
plan that is expected to improve services, safety, treatment,
housing, and public education for people with Alzheimers
disease and other forms of dementia.45 The plan is the
product of a six month consultation process that brought
elected officials from both political parties together with
patients, families, advocates, and 50 experts representing
education, health care, public safety, financing, housing and
transportation.46 It features recommendations in five areas:

40. ALZHEIMERS ASSN, STATE ALZHEIMERS DISEASE PLANS 1,
http://act.alz.org/site/DocServer/STATE_AD_PLANS.pdf?docID=4641
(last
visited Oct. 2, 2015).
41. Coll. of Pub. Health: Inst. of Gerontology, Community, UGA
Collaborate on Alzheimers Registry, UNIV. OF GA. (June 16, 2014),
http://www.publichealth.uga.edu/geron/news/community-uga-collaboratealzheimer%E2%80%99s-registry (Georgia is only the third state to create
such a tool useful for research, first responders, policy makers, caregivers, and
families.).
42. See S. 14, 152d Gen. Assemb., Reg. Sess. § 1 art. 9 (Ga. 2013) (The
General Assembly finds and declares that Alzheimers disease is a looming
national public health crisis and impacts every state.).
43. Id.
44. Id.
45. Press Release, Ga. Dept of Human Servs., Georgia Releases First
State Dementia Plan (Jul. 1, 2014), https://dhs.georgia.gov/pressreleases/2014-07-01/georgia-releases-first-state-dementia-plan
(announcing
the release of the plan); GA. ALZHEIMERS DISEASE & RELATED DEMENTIAS
STATE PLAN TASK FORCE, GEORGIA ALZHEIMERS AND RELATED DEMENTIAS
STATE PLAN 2 (2014), https://dhs.georgia.gov/sites/dhs.georgia.gov/files/GARDPLAN.pdf.
46. Toni P. Miles, Unsafe At Any AgeGeorgias New Gun Law vs. State
(Aug.
4,
2014),
Alzheimers
Plan,
NEWAMERICANMEDIA.ORG
http://newamericamedia.org/2014/08/unsafe-at-any-agegeorgias-new-gunlaw-vs-state-alzheimers-plan.php; see also GEORGIA ALZHEIMERS AND

230

MINN. J. L. SCI. & TECH.

[Vol. 17:1

healthcare, research, and data collection; workforce
development; service delivery; public safety; and outreach and
partnerships.47 Each area features a set of goals and
corresponding strategies.48
B. SCOPE AND OBJECTIVE OF THE GEORGIA REGISTRY
The reported incidence of Alzheimers disease in the aging
population is increasing at an alarming rate both nationwide
and in Georgia,49 and this may represent just the tip of the
iceberg.50 Many people do not enter the medical system until
the later stages of the disease, after they have developed other
chronic illnesses such as diabetes or heart disease,51 which are
often easier to diagnose.52 To improve data collection on actual
Alzheimers disease incidence, this year, Georgia introduced its
own population-based registry.53 The Alzheimers disease
registry was created in order to provide accurate data for
research and policy planning,54 including identification of
Alzheimers/dementia risk factors and identification of
RELATED DEMENTIAS STATE PLAN, supra note 45, at 39 (listing the various
collaborators to the Plan).
47. GEORGIA ALZHEIMERS AND RELATED DEMENTIAS STATE PLAN, supra
note 45, at 3940.
48. Id. at 4058.
49. Id. at 89 (In the past six years alone, the number of Georgians
reporting symptoms of dementia increased by 22 percent to 120,000  this is a
427% increase from the 1985 estimates.).
50. See id. at 16 (stating that the exact number of Georgians with
dementia is unknown).
51. For a discussion on how late diagnoses is a major problem among
minority populations that are already at greater risk for developing
Alzheimers and related diseases, see Brenda Patoine, Alzheimers and
Dementia in Minority Populations: Unraveling Risks, Overcoming Barriers,
DANA
FOUND.
(2015),
http://www.dana.org/Briefing_Papers
THE
/Alzheimer_s_and_Dementia_in_Minority_Populations__Unraveling_Risks__O
vercoming_Barriers/. For a more detailed discussion of the impact of
Alzheimers and dementia on minorities, see Part V.
52. Cf. ALZHEIMERS ASSN, 2015 ALZHEIMERS DISEASE FACTS AND
FIGURES:
DISCLOSING
A
DIAGNOSIS
(MAR.
2015),
https://www.alz.org/facts/downloads/ff_quickfacts_2015.pdf (Less than half
(45 percent) of seniors diagnosed with Alzheimers disease or their caregivers
are aware of the diagnosis, compared with 90 percent or more of those
diagnosed with cancer and cardiovascular disease. (emphasis added)).
53. See GEORGIA ALZHEIMERS AND RELATED DEMENTIAS STATE PLAN,
supra note 45, at 61 app. I (presenting the number of individuals at-risk for
Alzheimers and related dementias in the Georgia population).
54. See GA. CODE ANN. § 31-2A-17 (2015).
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demographic
groups
in
which
the
prevalence
of
Alzheimers/dementia is higher. 55
The Georgia Department of Public Health (DPH) is tasked
with the responsibility of promulgat[ing] rules and regulations
for the establishment and operation of the registry.56 The DPH
must collect and evaluate prevalence data, create data
retention policies, create appropriate data sharing policies for
researchers and public policy makers, and create a system to
both gather additional data from patients and inform them
about available resources.57 Currently, the promulgation of the
procedural rules is still ongoing within the DPH. As part of the
rulemaking process, DPH sought public comment and input
from a wide range of stakeholders.58 In July 2014, the Institute
of Gerontology at the University of Georgia59 convened a daylong meeting to develop a set of comments for submission to
DPH, as described in the next section.60
C. STAKEHOLDERS EFFORTS TO ESTABLISH REGISTRY
On June 16, 2014, in order to involve the broader
Alzheimers disease community and address the questions of
various groups affected by the legislation, the University of
Georgia Institute of Gerontology hosted the Alzheimers
Disease Registry Stakeholder Conference.61 According to Dr.
Toni Miles,62 the key convenor, the conference was held as a
follow-up to a DPH meeting on May 22, 2014, in an effort to
give additional people an opportunity to contribute to the
conversation.63 Dr. Miles and co-convenors invited the
University of Georgia and Athens-Clarke County communities
to come together to discuss potential elements of and uses for
55. GEORGIA ALZHEIMERS AND RELATED DEMENTIAS STATE PLAN, supra
note 45, at 11.
56. Id.
57. Id.
58. See infra Part I.C.
59. Authors Weeks, Leonard, and Bu served as reporters and conveners,
under the Institutes Director, Dr. Toni Miles.
60. See Community, UGA Collaborate on Alzheimers Registry, supra note
41.
61. Id.
62. Dr. Miles is the current Director of the Gerontology Institute at the
University of Georgia and was the organizer of the Alzheimers Disease
Registry Stakeholder Conference. Id.
63. Id.
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the Registry.64 The University of Georgia community included
representatives from the Law School, the College of Public
Health, the Carl Vinson Institute of Government, and other
outreach divisions of the University that collaborate directly
with the surrounding communities.65 Athens-Clarke County
community members included law enforcement officers, health
workers, and representatives of local social service and other
nonprofits that support health or aging issues.66 The keynote
speaker was a neurologist from Emory University.67
Following an opening presentation related to current
diagnosis and treatment of Alzheimers and related dementias,
attendees were divided into groups of eight and ten people to
engage in a facilitated discussion. The break-out groups were
asked to consider the following questions:
1. Who are the end-users of this [R]egistry?
2. What type of information should be collected in the Registry?
3. How (or from whom) should the information be collected?
4. How should the information be shared or disclosed for policy
planning
[or
for]
research
purposes?68

The entire assembly then reconvened to report and compile
comments from the break-out groups.69
Regarding the end-users question, groups identified
[s]trategic planners, law enforcement, public safety[, c]ounty
government [particularly] as it plans budget related policies[,
. . . h]ospitals, [e]mergency [d]epartments, [e]state planners[,
and d]isaster and emergency evacuation planners.70 Regarding
the type of information to be collected, stakeholders listed: deidentified [d]emographics[; h]ealthcare utilization history and
community resources used by the individual[; l]iving
arrangements[; a]ssociated health conditions . . . [including the]
64. Id.
65. Id. (Participants represented the UGA Law School, Carl Vinson
Institute, Archway Partnership, College of Public Health, Emory University,
Cooperative Extension, Athens Community Council on Aging, Athens
Regional Health Systems, and Athens-Clarke County law enforcement.).
66. Id.
67. Conference Agenda, Univ. of Ga., Alzheimers Disease Registry
Stakeholder ConferenceNorth Georgia / Athens (June 16, 2014) (on file with
author) (showing Dr. James J. Lah as the keynote speaker).
68. Id.
69. Id.
70. Sponsored Stakeholders Meeting Memorandum, supra note 3, at 2.
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need for assistive technology[; and l]icenses held by the person
with dementia.71 Regarding how and from whom data should
be collected, the groups were reticent to mandate reporting by
health care providers.72 Instead, they suggested alternative
data sources such as Georgias Online Analytical Statistical
Information System (OASIS), [a]pplications for handicap
[parking] tags[, d]eath certificates, medical examiner[s], health
insurance claims[, l]aw enforcement calls[, and] allowing
patients and families to enter their own data.73 Finally, in
response to the question regarding disclosure for research
purposes, they suggested that aggregate, de-identified data
should be made widely available.74 They also suggested a
[r]estricted electronic version for researchers and budget
planners with a well-developed application process.75
Following the Stakeholder Conference, the conveners
debriefed, then summarized and reported the findings back to
DPH.76 The hope was that those comments would be included
with other, similar sets of comments to assist in promulgating
rules and regulations for the establishment and operation of
the Registry. The Registry and its online portal for submitting
data launched in March 2015. According to news reports, [i]t
will be populated by a mix of existing data sources from health
plans and government repositories, including Medicare and
Medicaid, and patient information reported by physicians.77
For now, only physicians may access the portal to report new
cases, and reporting is voluntary.78 No detailed reporting
procedures and requirements have been formalized.
71. Id.
72. Cf. id. (illustrating how health care providers are absent from the
suggested list of sources which data should be collected from).
73. Id.
74. Id.
75. Id.
76. Id. The Sponsored Stakeholders Meeting Memorandum was sent to
Brenda Fitzgerald, the State Health Commissioner at the Georgia
Department of Public Health. Id.
77. Nancy Nydam, Alzheimers Disease and Related Dementias Registry:
Georgias Blueprint for the Future, GA. DEPT PUB. HEALTH BLOG (Mar. 30,
2015),
https://dph.georgia.gov/blog/2015-03-30/alzheimer%E2%80%99sdisease-and-related-dementias-registry-georgia%E2%80%99s-blueprintfuture.
78. GA. DEPT PUB. HEALTH, GEORGIA ALZHEIMERS AND RELATED
DEMENTIAS
REGISTRY
(GARDR)
USERS
GUIDE
(2015),
http://dph.georgia.gov/sites/dph.georgia.gov
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II. OTHER COMPREHENSIVE POPULATION-BASED
ALZHEIMERS DISEASE REGISTRIES IN U.S.
Georgias Registry operates within long-established
strategies to address diseases affecting the publics health, but
is somewhat unique in targeting a widespread but noncontagious disease.79 Governments and public health officials
have long struggled to protect their citizens from health
crises.80 Over the past century, monitoring of and intervention
against specific diseases have become central features of public
health systems in most developed countries.81 Registry
systems designed to collect detailed data enabling governments
to track and prevent dangerous diseases are one of the most
widely used forms of government monitoring.82 Although the
vast majority of public health registries in the past century
have focused on collection of infectious disease data,83 registries
for non-infectious diseases, such as Alzheimers disease,
diabetes, and cancer, have also been created.84 In 1988, South
Carolina was one of the first states to begin collecting
information on Alzheimers disease diagnoses with a
population-based disease registry85 and was later followed by
/files/GARDR%20Provider%20User%20Guide.pdf (explaining how to add new
cases to the registry and search for existing cases). The Users Guide does not
specify who may or must report or identify other sources of data. Id.
79. See generally Beate Ritz et al., Can Lessons from Public Health
Disease Surveillance Be Applied to Environmental Public Health Tracking?,
113 ENVTL. HEALTH PERSP. 243, 24344 (2005) (describing the historical
strategies of tracking and researching contagious disease).
80. See id.
81. See id.
82. Harold J. Krent et al., Whose Business Is Your Pancreas? Potential
Privacy Problems in New York Citys Mandatory Diabetes Registry, 17 ANNALS
HEALTH L. 1, 7 (2008).
83. See, e.g., Scott F. Wetterhall et al., The Role of Public Health
Surveillance: Information for Effective Action in Public Health, 41 MORBIDITY
& MORTALITY WKLY REP. 207, 20910 (Supp. 1992); see also Ctrs. for Disease
Control & Prevention, Achievements in Public Health, 1900-1999: Control of
Infectious Diseases, 48 MORBIDITY & MORTALITY WKLY REPORT 621, 622624
(1999) (describing the history of controlling infectious diseases).
84. See Krent et al., supra note 82, at 12 (New Yorks diabetes registry
is the first in the nation to require collection of personal testing date for the
purpose of monitoring treatments for a noninfectious disease. (emphasis
added)).
85. See Caroline Macera et al., The South Carolina Alzheimers Disease
Patient Registry: A Progress Report, 6 AM. J. OF ALZHEIMERS CARE & RELATED
DISORDERS & RES. 3538 (Jan./Feb. 1991) (In April 1988, the American
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West Virginia in 2006.86 In 1984, the California legislature also
established the Alzheimer Disease Program (ADP) in the
California Department of Health Services (CDHS).87 In 1986,
New York State established the Alzheimers Disease and Other
Dementias Registry.88 The New York and California registries
operate mostly from voluntary reporting and are
underutilized.89 Because we anticipate more rigorous
enforcement of Georgias Registry, for the purpose of this
article, we will focus on the experiences of South Carolina and
West Virginia.
A. SOUTH CAROLINA
The South Carolina Alzheimers Disease Registry (South
Carolina Registry), previously the Statewide Alzheimers
Disease and Related Disorders Registry, is a comprehensive
statewide [population-based] registry of SC residents diagnosed
with Alzheimers disease.90 In South Carolina, Alzheimers
disease is notoriously prevalent.91 About 11.5% of people over
age sixty-five and 42.7% over age eighty-five have Alzheimers
disease, according to a data comparison from 2004 to 2008.92 As

Health Assistance Foundation . . . provided major funding to establish a
registry of persons in South Carolina.).
86. Blanchette Rockefeller Neurosciences Inst., West Virginia Alzheimers
VA.
UNIV.,
Disease
Registry:
Registry
History,
W.
http://www.wvadr.hsc.wvu.edu/registry-history/ (last visited Sept. 13, 2015).
(stating that the West Virginia registry is [b]ased on the model developed in
South Carolina.).
87. See California Alzheimers Disease Program, CAL. DEPT OF PUB.
HEALTH,
http://www.cdph.ca.gov/programs/alzheimers/Pages/default.aspx
(last updated July 10, 2015).
88. Patricia P. Lillquist, Challenges in Surveillance of Dementias in New
CHRONIC
DISEASE
1
(2004),
York
State,
1
PREVENTING
http://www.cdc.gov/pcd/issues/2004/jan/03_0011.htm.
89. See California Alzheimers Disease Program, supra note 87; see also
Lillquist, supra note 88, at 2 (Reporting is mandated for physicians and
facilities . . . .).
90. Off. for the Study of Aging, Alzheimers Disease Registry, UNIV. OF
S.C. ARNOLD SCH. OF
PUB. HEALTH, http://www.sph.sc.edu/osa
/alzheimers_registry.html (last visited Sept. 13, 2015).
91. See generally UNIV. OF S.C. ARNOLD SCH. OF PUB. HEALTH, ANNUAL
REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE REGISTRY 2012, at 12
(2012),
http://www.sph.sc.edu/osa/2012%20Annual%20Report_FINAL.pdf
(The number of new cases added to the Registry has increased from 20042008 at an average of 2.9% per year.).
92. Id. at 1.

236

MINN. J. L. SCI. & TECH.

[Vol. 17:1

the most comprehensive Alzheimers disease registry in the
United States, the South Carolina Registry has maintained a
record of diagnosed cases in the state since January 1, 1988.93
The South Carolina Registry could not have been established
without joint efforts from non-profit organizations and state
government at that time.94
The South Carolina Registry comprises multiple data
sources, including inpatient hospitalizations, mental health
records, state health plans, Medicaid, emergency departments,
memory clinics, vital records, and long-term care evaluations.95
The South Carolina Registry is maintained by the Arnold
School of Public Health of the University of South
Carolina . . . , in cooperation with the South Carolina
Department of Health and Human Services . . . , the SC
Department of Mental Health, the USC School of Medicine, and
the SC Office of Budget and Control.96
Reporting to the South Carolina Registry is voluntary.97
The core data collected are age, type of dementia, gender, and
race.98 International Classification of Diseases (ICD-9)99 data
codes are recorded.100 Additional data sets on certain
populations include educational status, caregiver contact, and

93. See id.
94. In April 1988, the American Health Assistance Foundation in
Rockville, Maryland, provided major funding to establish a registry of persons
in South Carolina who have been diagnosed with dementia, particularly
Alzheimers disease. This funding was matched by the state Health and
Human Services Finance Commission, and with supplemental funding from
the Association of Schools of Public Health, and the Centers for Disease
Control. Macera et al., supra note 85, at 35.
95. ANNUAL REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE
REGISTRY 2012, supra note 91, at 5 fig.1.
96. Id. at 1.
97. Id. at 6.
98. Id. at 89.
99. The World Health Organization describes ICD as follows: [t]he
International Classification of Diseases (ICD) is the standard diagnostic tool
for epidemiology, health management and clinical purposes. This includes the
analysis of the general health situation of population groups. It is used to
monitor the incidence and prevalence of diseases and other health problems,
proving a picture of the general health situation of countries and populations.
International Classification of Diseases (ICD), WORLD HEALTH ORG.,
http://www.who.int/classifications/icd/en/ (last visited Oct. 2, 2015).
100. ANNUAL REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE
REGISTRY 2012, supra note 91, at 19.
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marital status.101 The law has strict confidentiality
requirements but does allow [South Carolina] Registry staff to
contact the families and physicians of persons diagnosed as
having Alzheimers disease . . . to collect relevant data and to
provide information about public and private health care
resources available to them.102
The South Carolina Registry has been extremely and
consistently effective with regard to its data collection
function.103 Since January 1, 1988, the [South Carolina]
Registry has identified a total of 199,279 cases of Alzheimers
[disease].104 The robustness and duration of the South
Carolina Registry provides useful insights for establishing the
Registry in Georgia.
B. WEST VIRGINIA
West Virginia provides another excellent model for
Georgias new Registry. West Virginia is particularly
vulnerable to an increased incidence of Alzheimers disease
because it has one of the oldest populations in the country, and
the risk factors for Alzheimers disease such as heart disease,
diabetes, high cholesterol, smoking, and high blood pressure
are all higher in West Virginia than the national average.105
Thirty-six thousand people in West Virginia were estimated to
have Alzheimers disease in 2014.106 By 2025, there will be an
estimated 22.2% increase in Alzheimers disease in the state.107
The West Virginia Alzheimers Disease Registry [(West
Virginia Registry)] is a state-mandated, population-based

101. Id. at 19; see also S.C. CODE ANN. § 44-36-10 (2014) (describing which
data sources the Registry should rely upon).
102. ANNUAL REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE
REGISTRY 2012, supra note 91, at 6; see also S.C. CODE ANN. § 44-36-30 (2015)
(establishing that patient information is confidential).
103. See ANNUAL REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE
REGISTRY 2012, supra note 91, at 1 (describing the amount of data the
Registry has collected since its genesis).
104. Id.
105. ALZHEIMERS ASSN: WEST VIRGINIA CHAPTER, MAKE A PLAN FOR
ALZHEIMERS IN WEST VIRGINIA: FINAL REPORT AND RECOMMENDATIONS app.
(Dec.
12,
2011),
http://www.alz.org/national
/documents/WV_StatePlanMap.pdf.
106. 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note 5, at 22
tbl.2.
107. Id.
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registry of patients with Alzheimers.108 It has been in
existence since 2006 and is currently located at and maintained
by West Virginia University.109 The West Virginia Registry is
a password-protected, encrypted database requiring annual
software costs, as well as personnel, to enter, manage and
analyze the data.110
Registry data will populate statistical summaries of demographic,
diagnostic and treatment information that will be used to advise
physicians, patients, caregivers and policymakers at local and state
levels about the medical, social and economic impact of Alzheimers
in West Virginia. Collaterally, it is anticipated that the collection of
this data will improve the diagnosis, treatment and care of patients
with Alzheimers disease, and it will educate policymakers about the
size of the problem and necessity of state funding for care and
support.111

The West Virginia legislature created the West Virginia
Registry under the Alzheimers Special Care Standards Act in
2006,112 based on a similar statute in South Carolina,113 and it
first received funding in 2009.114 Active operation of the West
Virginia Registry began in 2010.115 The statute mandated that
all reporting sources including hospitals, physicians, facilities,
clinics or other similar units diagnosing or providing treatment
or care for Alzheimers disease and related disorders, shall
provide a report of each case to the West Virginia Registry.116
This means the Legislature has made reporting mandatory. In
practical terms, only a physician can diagnose and treat a
patient with dementia so a physician or one of their staff would

108. MAKE A PLAN FOR ALZHEIMERS IN WEST VIRGINIA: FINAL REPORT AND
RECOMMENDATIONS, supra note 105, at 3.2.
109. See West Virginia Alzheimers Disease Registry, supra note 27 (SB
112 passed on March 11th, 2006, was signed by Governor Joe Manchin and
became law on June 11th, 2006.); W. VA. CODE § 16-5R-7(a) (granting the
Governing Board of West Virginia University the authority to establish an
Alzheimers disease registry).
110. See MAKE A PLAN FOR ALZHEIMERS IN WEST VIRGINIA: FINAL REPORT
AND RECOMMENDATIONS, supra note 105, at 3.2.
111. Id.
112. W. VA. CODE §16-5R (2014); West Virginia Alzheimers Disease
Registry, supra note 27.
113. See West Virginia Alzheimers Disease Registry, supra note 27.
114. See MAKE A PLAN FOR ALZHEIMERS IN WEST VIRGINIA: FINAL REPORT
AND RECOMMENDATIONS, supra note 105, at 3.2.
115. See id. at The Map Process (The Make a Plan (MAP) for Alzheimers
initiative kicked off in February 2011.).
116. W. VA. CODE §16-5R-7(b) (2015).
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be required to report patient information to the Registry.117
This reporting requirement meets the HIPAA exception as a
public health authority activity, which will be discussed in
greater detail in Section III of this Article.118 The details of
data to be collected and procedures for their collection are
further outlined in Section IV below, in which we more closely
examine the West Virginia Procedural Rules for guidance for
Georgia.119
C. GEORGIA FEATURES AND LESSONS LEARNED
The Georgia Registry has many of its own unique
features.120 Some of them bear important distinctions from the
other two registries, particularly the South Carolina Registry.
For example, the South Carolina Registry is explicitly intended
to support Alzheimers disease research by monitoring patients
closely, testing frequently, and providing researchers with
access to de-identified data.121 The Georgia General Assembly,
however, was silent regarding whether the Registry is intended
to support research on genetic, environmental, and sociological
risk factors for development of Alzheimers disease.122 Rather,
the law suggests that the data will be used primarily for
purposes of public health statistical gathering and policy
planning.123 In other words, at the legislative level, the
Registry is primarily intended to estimate the prevalence of
dementia in the general population and help the government
make sound public health policies.124 The Task Forces 2014
State Plan, however, expressly identified collection and use of

117. Bernard G. Schreurs, The West Virginia Alzheimers Disease Registry,
107 W. VA. MED. J. 44, 45 (2011).
118. W. Va. Alzheimers Disease Registry, HIPAA Compliance, W. VA.
UNIV., http://wvadr.hsc.wvu.edu/Physicians-Corner/HIPAA-Compliance (last
visited Sept. 13, 2015); see infra Part III.
119. See infra Part IV.
120. See generally H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014)
(presenting the features of a Alzheimers disease registry in Georgia).
121. S.C. CODE ANN. § 44-36-10(B) (2015).
122. See GA. CODE ANN. § 31-2A-17 (2015).
123. GA. CODE ANN. § 31-2A-17(b) (2015) (The purpose of the registry
shall be to assist in the development of public policy and planning.).
124. See GA. CODE ANN. § 31-2A-17(c)(1) (2015) (establishing that the
Registry is for [c]ollecting and evaluating data regarding the prevalence of
Alzheimers disease and related disorders in Georgia.).
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information for research purposes as one objective of the
Registry.125
Other comparisons between existing state registries and
Georgias Registry merit comment. Both the West Virginia and
Georgia legislatures enacted broad statutory authorization for
the registries while delegating promulgation of detailed
implementation and procedural rules to other entities.126 In
Georgia, the legislature delegated that authority to a state
agency, the Georgia Department of Public Health, whereas in
West Virginia and South Carolina, academic institutions house
the registries and provide rules for their operation.127 Georgias
approach takes advantage of the institutional knowledge of the
Georgia DPH public health administration and comports with
the broader policy planning, not merely research, objectives of
the Registry.128
Distinct features of the Registry in Georgia suggest that
lawmakers have learned important lessons from the other two
registries. The experiences of these pioneering states may also
be useful for other states considering establishing a similar
Alzheimers disease registry.129 The South Carolina Registry,
since its inception in 1988, relied heavily on statistical and
demographic sources by culling information from hospital
records, Medicaid documents, memory clinic records, mental
health records, vital records and long term care evaluations to
help understand the disease more fully.130 Recently, in 2009,
125. See GEORGIA ALZHEIMERS AND RELATED DEMENTIAS STATE PLAN,
supra note 45, at 4042.
126. GA. CODE ANN. § 31-2A-17(c) (2015) ([T]he department shall
establish procedures and promulgate rules and regulations for the
establishment and operation of the registry.); W. VA. CODE § 16-5R-7(d)
(2015) (The governing board shall propose rules pursuant to the provisions of
article three, chapter twenty-nine-a of this code to implement this section.).
127. See GA. CODE ANN. § 31-2A-17(a) (2015) (There is established within
the Department of Public Health the Alzheimers Disease Registry.); W. VA.
CODE, § 16-5R-7(a) ([T]he Governing Board of the West Virginia University
shall establish an Alzheimers Disease Registry.); S.C. CODE ANN. § 44-3610(B) (2015) (There is established within the University of South Carolina
School of Public Health the Alzheimers Disease Registry.).
128. GA. CODE ANN. § 31-2A-17 (2015).
129. See GA. CODE ANN. § 31-2A-17(a) (2015).
130. Michael Jeffcoat, New Alzheimers Disease Research Bill Being Sent to
South Carolina Governor Mark Sanford, S.C. NURSING HOME LAWYER BLOG
(June
3,
2009),
https://web.archive.org/web
/20090722154453/http://www.southcarolinanursinghomelawyerblog.com/2009/
06/new_alzheimers_disease_researc.html].
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South Carolina amended the law to allow Registry analysts to
have direct contact with families and caregivers who are deeply
affected by Alzheimers disease and possess unique information
about patients.131 Those analysts directly assess and report the
hardships and lifestyle changes that Alzheimers patients and
their support systems face.132 Georgia has taken a more
proactive approach from the Registrys inception: families and
physicians of persons who are reported to the registry shall be
contacted to gather additional data.133
The Registry also has emphasized, from the outset, the
importance of protecting the confidentiality of patient data
from secondary uses.134 According to the Georgia legislation,
all persons to whom the data is released shall maintain
patient confidentiality.135 For example, when a researcher
wants to analyze links between Alzheimers disease and
socioeconomic characteristics, such as health education,
literacy, and alcohol abuse, the researcher has strict obligations
to safeguard such information.
Alzheimers disease registries operate very differently from
typical public health registries.136 [G]overnments have often
mandated registry and treatment in the case of infectious
diseases.137 [S]uch infringement on personal choice and
privacy has been justified by the overriding need to protect the
public from the spread of dangerous disease.138 It is a different

131. 2009 S.C. Acts 728 ([T]he registry may contact families and
physicians of persons reported to the registry for the purpose of gathering
additional data and providing information on available public and private
resources.).
132. See S.C. CODE ANN. § 44-36-10(C) (2015) (The registry is authorized
to conduct follow-back studies . . . of the progression and treatment of
Alzheimers disease and related disorders, and research on caregiving for . . .
[and] services used by individuals with Alzheimers disease.).
133. GA. CODE ANN. § 31-2A-17(c)(5) (2015).
134. Id. at (d) (The collected data in the registry shall be confidential.).
135. Id.
136. Compare Amy Fairchild et al., Public Goods, Private Data: HIV and
the History, Ethics, and Uses of Identifiable Public Health information, 122
PUB. HEALTH REP. 1, 8 (2007) (When deemed appropriate, health officials
released the names and addresses of those with contagious diseases in order to
fulfill a duty to warn the public.), with Schreurs, supra note 117, at 45
(Access to patients private health information is restricted to the Director of
the [West Virginia] Registry.).
137. Krent et al., supra note 82, at 11.
138. Id. at 1112.
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story for non-infectious disease registries, such as a cancer,
diabetes, or Alzheimers disease registry.139 Existing state-run
Alzheimers disease registries rely on voluntary reporting to
avoid releasing or publishing identifiable individual data.140
Use of individual data for policy planning and research related
to non-infectious diseases, such as Alzheimers disease and
related dementia, raises potential legal and ethical concerns
that merit thorough discussion.141 Therefore, best practices for
Registry implementation in Georgia and elsewhere should be
attuned to those unique considerations.
III. LEGAL AND ETHICAL CONCERNS OF THE REGISTRY
This Section explores the legal and ethical issues raised by
the Registry. An Alzheimers disease patients diagnosis
history, medication history, and personal lifestyle are generally
confidential information, known only to the physician and
patient himself. Reporting such information to the Registry,
however, may lead to wider disclosure of what was previously
private
information
and
consequently
may
arouse
constitutional concerns. Furthermore, despite the statutory
pledge of confidentiality and HIPAA compliance, the risk of
disclosure through cyber invasion or public health officials
errors remains present. Moreover, some patients may object to
secondary use of their information in research projects of which
they disapprove. Finally, physicians professional ethics may
also be undermined if the registry information is disclosed.
After considering these areas of concern, we conclude by
recommending
various
best
practices
for
avoiding
confidentiality breaches before implementation of the Registry
in Georgia or other states.

139. See id. at 12 (Cancer registries . . . have been motivated largely by
the desire to identify and mitigate environmental and occupational risks . . . .
The few registries that are already in place for diabetes, rather than
mandating enrollment, rely on patient and doctor consent.).
140. See, e.g., ANNUAL REPORT OF SOUTH CAROLINA ALZHEIMERS DISEASE
REGISTRY 2012, supra note 91, at 4, 6.
141. Krent et al., supra note 82 (discussing privacy in the context of a
diabetes registry).
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A. CONSTITUTIONALITY OF THE REGISTRY
A population-based disease registry is essential to
identifying the breadth and impact of the targeted disease.142 It
facilitates research and policymaking to learn what causes the
target disease to develop and how to deal with it.143 But even
traditional, well-established disease registries have come under
constitutional scrutiny. Patients have challenged some state
registries of health information as unjustifiable invasions of the
right of privacy afforded by the U.S. Constitution,144 a right
that the Supreme Court has interpreted to include
confidentiality of medical records.145 Specifically, the
constitutional challenges alleged that the state registries are
unconstitutional due to 1) the vagueness of statutory aims to
pursue public health . . . [as compared to the recognized]
individual privacy interests of cancer patients, and 2) the
alleged indignity of ones individual medical information being
transmitted to government authorities.146 Contrary to the
vagueness claims, most enabling statutes of disease registries
define specific aims and activities, categories of data to be
gathered, reasons for doing so, and rigorous criteria for access
to and release of . . . [disease] data.147 Accordingly, the first
theory of unconstitutionality is largely unavailing.
Regarding the second theory, Whalen v. Roe has been
described as the seminal case on the issue of balancing
. . . patient privacy and [the] government[s] need for
information148 and establishes precedent for recognizing an
142. See Population-Based Registries, supra note 4.
143. Id.
144. Compare Whalen v. Roe, 429 U.S. 589, 60304, 604 n.32 (1977)
(analyzing constitutional protections of privacy emanating from the Fourth
and Fourteenth Amendments), with Schulman v. N.Y.C. Health & Hosps.
Corp., 342 N.E.2d 501, 50607 (N.Y. 1975) (applying Fourteenth Amendment
Equal Protection jurisprudence).
145. Each of the courts in the Schulman and Whalen cases, both supra
note 144, declined to extend federal constitutional privacy rights to the instant
circumstances (pregnancy termination certifications and patient-identification
requirements, respectively). In their analyses, however, the courts did identify
situations where constitutional privacy protections might apply. Id.
146. See Robert H. McLaughlin et al., Are Cancer Registries
Unconstitutional? 70 SOC. SCI. & MED. 1295, 1295 (2010).
147. Id. at 1296. The studies discussed in the McLaughlin et al. article
focus primarily on state cancer registries.
148. Fort Wayne Womens Health v. Bd. of Commrs, 735 F. Supp. 2d 1045,
1059 (2010).
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individuals right to conceal his medical information.149 In
Whalen, the United States Supreme Court upheld a statute
that required that the names, addresses, and prescription
details for all persons receiving Schedule II controlled
substances to be reported to the New York State Department of
Health.150 The Court found that the statutes at issue advanced
legitimate state interests and that the registrys purpose to aid
in the enforcement of laws designed to minimize the misuse of
dangerous drugs amounted to a reasonable exercise of New
Yorks broad police powers.151
The Court also noted that the statute did not interfere with
physician-patient decision-making,152 and it included explicit
confidentiality provisions protecting patient information from
public disclosure.153 At the time the case was brought, exactly
seventeen health workers and twenty-four investigators were
authorized to access the data, and willful unauthorized
disclosure could result in a $2000 fine and up to a year in
prison.154 The data were kept in a locked, secure area, and
computers were brought offline before the computer tapes could
be used, preventing any access to the data by outside
terminals.155 Finally, the Court noted that during the twenty
months in which the law had been in place, there was no
evidence that it had deterred patients from seeking needed
medications.156
Similarly, in Schulman v. New York City Health and
Hospitals Corporation, the New York Court of Appeals upheld
a statute requiring that patients file a certificate of termination
of pregnancy after receiving an abortion.157 The court stated
that [c]ourts have generally not found that the privacy interest
149. Planned Parenthood of Indiana v. Carter, 854 N.E.2d 853, 871 (Ind.
Ct. App. 2006).
150. Whalen, 429 U.S. at 59294.
151. Id. at 598.
152. Id. at 603 (Nor can it be said that any individual has been deprived of
the right to decide independently, with the advice of his physician, to acquire
and to use needed medication.).
153. Id. at 594 n.12 (quoting New York Department of Health regulatory
language regarding the duty of confidentiality).
154. Id. at 59495.
155. Id.
156. Id. at 603.
157. Schulman v. N.Y.C. Health & Hosps. Corp., 342 N.E.2d 501 (N.Y.
1975).

2016]

BEST PRACTICES

245

extends to situations in which the government gathers personal
information for legitimate purposes.158 It also found that the
statute at issue was narrowly tailored to further legitimate
state interests, including providing a broad sampling of data to
further research and public policy goals.159 The court noted that
there are restrictions on disclosure of information about
patients and found no evidence that this statute would lead to
public disclosure of information or have a chilling effect on
abortions.160 Applying the rational basis test, the court found
that the statute was narrowly tailored to [further] the
compelling [State] interest in maternal health during the
second trimester of pregnancy.161
The New York case was distinguished by Hawaii
Psychiatric Society, District Branch of the American Psychiatric
Association v. Ariyoshi, where the federal District Court in
Hawaii issued a preliminary injunction in favor of a
psychiatrist whose records were copied by a representative of
the Medicaid Fraud Unit (under the Department of the
Attorney General).162 The relevant statute required providers
receiving Medicaid funds to keep records for three years and
authorized the issuance of warrants to inspect and copy such
records.163 An administrative inspection warrant was issued for
all therapeutic notes, patient history forms, and medical
records, reports, and diagnoses based solely upon an affidavit
stating that the psychiatrists office had never been inspected
and it was in the public interest to inspect it.164 After finding
that the psychiatric association had standing to assert the
rights of its members,165 the court issued a preliminary

158. Id. at 506.
159. Id. at 503 (listing seven public health objectives, and noting the
particular need for such information-sharing to provide adequate medical care
for indigent women).
160. See id. at 504 (The record is completely devoid of any proof that the
name requirement dissuades potential abortion recipients from obtaining
abortions in New York City.).
161. Id. at 507.
162. Haw. Psychiatric Socy, Dist. Branch of American Psychiatric Assn v.
Ariyoshi, 481 F. Supp. 1028 (D. Haw. 1979).
163. Id. at 103334.
164. Id. at 103435.
165. Id. at 1037. The Court cited, as a comparison, the standing analysis
pertaining to the doctor-plaintiffs in Griswold v. Connecticut, 381 U.S. 479,
484 (1965). Id.
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injunction for the psychiatrist.166 Because the nature of the
information revealed in a psychiatric session was of an
extremely private nature, and due to the potential effect that
disclosure of such communications could have on a patients
decision to seek medical care, the court found that a compelling
interestrather than lower level rational basistest was
appropriate.167 It also concluded that while the state was
furthering a compelling state interest, it was not doing so in
the least restrictive manner possible.168 The Attorney Generals
office did not show any evidence that its need could not be
satisfied by looking at records with the personally identifiable
information redacted.169
B. GEORGIA CONSTITUTIONAL RIGHT TO PRIVACY
The U.S. Supreme Court precedent in Whalen is
instructive but not necessarily controlling of similar challenges
that could be brought under Georgias constitution.170 In
Georgia, citizens have a liberty of privacy guaranteed by the
Georgia constitutional provision which declares that no person
shall be deprived of liberty except by due process of law.171
This right of privacy guaranteed by the Georgia Constitution is
far more extensive than analogous protections under the U.S.
Constitution.172 Accordingly, invasion of privacy could
potentially be a constitutional pitfall for the Georgia Registry.
In addition, the Registrys purpose is arguably distinguishable
and, therefore, less defensible than the state purpose asserted
for the prescription registry in Whalen. New York was tracking
criminal behavior in the Whalen case;173 by contrast, the
166. Id. at 1052.
167. Id. at 1039 ([E]ven a burdensome regulation may be validated by a
sufficiently compelling state interest.).
168. Id.
169. Id. at 1042. This decision was criticized by the Seventh Circuit Court
of Appeals. Shields v. Burge, 874 F.2d 1201, 1211 (1989) ([W]e cannot say
that . . . the district court cases clearly established that the privacy rights
autonomy strand protects the decision to seek psychological or psychiatric
help.).
170. See King v. State, 535 S.E.2d 492, 495 (Ga. 2000) (noting that
Georgia recognizes an even broader concept of privacy than that under the
Federal Constitution).
171. Powell v. State, 510 S.E.2d 18, 21 (Ga. 1998).
172. King, 535 S.E.2d at 494.
173. Whalen v. Roe, 429 U.S. 589, 589 (1977).

2016]

BEST PRACTICES

247

Registry will be used to monitor the health of private
citizens.174
Despite these differences, it is likely that the Registry
would survive a potential constitutional challenge.175 Like the
statute at issue in Whalen, the enabling statute of the Registry,
namely House Bill 966, does not directly interfere with patient
or physician decision-making.176 Additionally, it contains a
brief confidentiality provision that limits disclosure to all the
people to whom the data is released.177 Thus, House Bill 966
satisfies the two factors that the court in Whalen considered in
determining the constitutionality of those registries.178
Furthermore, a detailed statement of the basis and purpose of
the Registry, which would likely support the rational basis
review of the statute, was included in the statute.179
Of particular relevance to the Registry, Georgia courts
have interpreted the state constitutional liberty of privacy
right as pertaining to medical information.180 That position was
most clearly outlined in King v. State.181 There, the Supreme
Court of Georgia explained that medical information . . . is
certainly a matter which a reasonable person would consider to
be private.182 The court further provided that [m]edical
174. GA. CODE ANN. § 31-2A-17(b) (2015).
175. Similar state registries have been upheld as valid exercises of state
police powers. See, e.g., Rollins v. Ulmer, 15 P.3d 749, 75354 (Alaska 2001)
(upholding constitutionality of medical marijuana registry on grounds that the
scheme assured confidentiality, at least on its face, and assuming that the
measure rationally allowed for compliance with rules regulating marijuana
use); Ark. Dept of Human Serv. v. Heath, 848 S.W.2d 927, 928 (Ark. 1993)
(holding that a registry for unsubstantiated allegations of child abuse is
permissible).
176. See H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014) (showing that
the bill is silent on physician and patient decision-making).
177. GA. CODE ANN. § 31-2A-17(d) (2015).
178. Whalen, 429 U.S. at 599600 (The cases sometimes characterized as
protecting privacy have in fact involved at least two different kinds of
interests. One is the individual interest in avoiding disclosure of personal
matters, and another is the interest in independence in making certain kinds
of important decisions. (internal footnotes omitted)).
179. See GA. CODE ANN. § 31-2A-17(b) (2015) (The purpose of the registry
shall be to assist in the development of public policy and planning.).
180. See, e.g., King, 535 S.E.2d at 495. ([T]he personal medical records of
this states citizens clearly are protected by that right as guaranteed by our
constitution.).
181. Id. at 492.
182. Id. at 495.
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records are entitled to more privacy than bank records and
phone records.183 Under the state constitutional protection,
such records cannot be disclosed without patient consent unless
otherwise required by a law of Georgia.184 King further
specifies that any statute compelling disclosure of such
information must effectuate[] a compelling state interest and
. . . [be] narrowly tailored to promote only that interest.185
In King, the police had issued a subpoena to a hospital in
order to gain access to the clients medical records to prove that
she had been driving while intoxicated.186 The prosecution cited
Georgia Code § 24-9-40(a), which states that no physician
. . . and no hospital or health care facility . . . shall be required
to release any medical information concerning a patient except
. . . on appropriate court order or subpoena . . . , as the statute
implicitly requiring the hospital to release the information.187
Citing Powell v. State,188 the court explained that [b]efore the
State is authorized to exercise its police power, it must appear
that the means are reasonably necessary for the
accomplishment of the purpose, and not unduly oppressive
upon the individuals.189 The court noted that the Fourth
Amendment requires the state to demonstrate probable cause
to an impartial arbiter before it is allowed to infringe upon an
individuals expectation of privacy.190 If the states
interpretation of § 24-9-40(a) was to prevail, such safeguards
could be circumvented, and the state could have almost
unfettered access to personal records.191 Although this would
further the states compelling interest in law enforcement, the
court found that it would not be reasonable and that it would
be highly oppressive.192
It is worth noting that courts in different states have
decided the privacy of medical records issue differently. The
183. Id. (quoting Thurman v. State, 861 S.W.2d 96, 98 (Tex. App.1993)).
184. Id.
185. Id.
186. Id.
187. Id.
188. Powell v. State, 510 S.E.2d 18 (Ga. 1998).
189. King, 535 S.E.2d at 496.
190. See id.
191. [T]he States interpretation of this statute would authorize the
disclosure of confidential information by means of a subpoena issued upon the
mere filing of an indictment or accusation, if not before. Id.
192. Id.
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Supreme Court of New Hampshire expressly disagreed with
King, arguing that the Supreme Court of Georgia placed
greater protection on privacy than that which would be
considered reasonable by society.193 On the other hand, in
Planned Parenthood of Indiana v. Carter, the Supreme Court of
Indiana cited King and also found that a right to privacy of
medical records exists.194
There have been multiple Georgia decisions narrowing
King. In another case entitled King v. State (King II), the court
found that the defendants right to privacy was not violated
when his medical records were obtained via a search
warrant.195 Two years later, King II was followed by Ellis v.
State.196 In King II and Ellis, the court stated that the need to
show probable cause to an impartial arbiter in order to obtain a
search warrant sufficiently protected individual privacy rights
and made the invasion of privacy reasonable.197
In addition, Georgia courts have affirmed substantial civil
judgments based on violations of the right to privacy. For
example, in Multimedia WMAZ, Inc. v. Kubach, the Court of
Appeals affirmed a civil judgment against a television station
that inadvertently revealed the identity of an HIV positive
interviewee to the public.198 The plaintiff agreed to do an
interview about AIDS and drug use on the condition that his
identity remain concealed.199 The court ruled that the plaintiff

193. State v. Davis, 12 A.3d 1271, 1274 (N.H. 2010).
194. Planned Parenthood of Indiana v. Carter, 854 N.E.2d 853, 873 (Ind.
Ct. App. 2006) (Although . . . [a previous decision by this court] did not
specifically hold that a federal constitutional right of privacy in medical
information exists, today we join our colleagues on the Seventh Circuit and
elsewhere in concluding that it does.).
195. King v. State (King II), 577 S.E.2d 764, 76667 (Ga. 2003)
(distinguishing on the basis that procedural safeguards when issuing search
warrants already provide the kind of privacy protections at issue in the first
King case).
196. Ellis v. State, 622 S.E.2d 89, 91 (Ga. Ct. App. 2005).
197. Id. at 91 ([E]xisting search warrant procedures provide adequate
protections for a defendants privacy rights under both the Georgia and United
States Constitutions.); King II, 577 S.E.2d at 764 (Because a search warrant
requires a neutral judicial officer to find probable cause that a crime has been
committed, we hold that a defendants constitutional right to privacy is not
violated . . . .).
198. Multimedia WMAZ, Inc. v. Kubach, 443 S.E.2d 491 (Ga. Ct. App.
1994).
199. Id. at 493.
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had not waived his privacy right by doing other television
interviews in which his back was visible and his voice was not
disguised, or by sharing his HIV status with friends and
family.200 The court affirmed a $500,000 award of damages but
reversed the $100,000 punitive award, finding insufficient
evidence of willful misconduct, malice, fraud, wantonness,
oppression, or that entire want of care which would raise the
presumption of conscious indifference to consequences to
support a punitive damages award.201
In determining the level of access to personal information
that should be granted to researchers and policymakers, one
must consider whether any potential law is likely to pass this
privacy inquiry. Addressing this burgeoning health problem is
likely to be deemed a compelling state interest, but any
invasion of privacy must be reasonable, narrowly tailored to
further that interest, and not unduly oppressive.202 In addition,
we should be aware of the possibility that the Registry could be
subject to civil actions if courts deem Alzheimers patients
privacy rights violated.203 Aside from the possible threat of
litigation, we recommend adopting practices that uphold
individuals constitutionally and statutorily protected privacy
rights.
C. THE HEALTH INSURANCE PORTABILITY AND
ACCOUNTABILITY ACT
In addition to federal and state constitutional concerns,
Registry implementation should be done in accordance with
federal statutory requirementsnamely, those required by the
Health Insurance Portability and Accountability Act
(HIPAA).204 HIPAA provides specific guidance for balancing
individual privacy concerns with researchers need for

200. Id. at 49394.
201. Id. at 49596 (quoting from GA. CODE ANN. § 51-12-5.1(b)).
202. See, e.g., King, 535 S.E.2d 492.
203. See, e.g., Kubach, 443 S.E.2d 491. To the extent that the Advisory
Council or DPH is a state actor, there could be thorny procedural and
jurisdictional hurdles, including sovereign immunity, to bringing a privacy
action under federal or state law. Those considerations are beyond the scope of
this Article.
204. Pub. L. No. 104-191, 110 Stat. 1936 (1996) (codified as subsequently
amended in scattered sections of 18 U.S.C., 26 U.S.C., 29 U.S.C., and 42
U.S.C.).
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information.205 One of the purposes of the Georgia Registry is
to provide Alzheimers data to policymakers;206 ideally, deidentified data should be widely available in a user-friendly
format. On the other hand, the Registry should restrict the
disclosure of individual, personally identifiable data in order to
respect individual privacy interests.
Congress, in enacting HIPAA, already grappled with
balancing those competing concerns, and regulations
implementing
HIPAA
provide
detailed
requirements
concerning the acquisition of personal health information for
research. The regulations, set out in the HIPAA Privacy Rule,
however, apply only to covered entities, defined as health
plans, health care clearinghouses, and . . . any health care
provider who transmits health information in electronic form in
connection with transactions for which the Secretary of HHS
has adopted standards under HIPAA.207 Because the Georgia
Registry is not a covered entity as defined by HIPAA,208 the
Privacy Rule does not strictly apply.
205. Indeed, [a] major goal of the Privacy Rule [45 C.F.R. §§ 164.50034]
is to assure that individuals health information is properly protected while
allowing the flow of health information needed to provide and promote high
quality health care and to protect the publics health and well being. U.S.
DEPT OF HEALTH & HUMAN SERVS.: OFFICE FOR CIVIL RIGHTS, SUMMARY OF
THE HIPAA PRIVACY RULE 1 (2003) [hereinafter SUMMARY OF THE HIPAA
PRIVACY
RULE],
http://www.hhs.gov/ocr/privacy/hipaa
/understanding/summary/privacysummary.pdf.
206. H.R. 966, 152d Gen. Assemb., Reg. Sess. § 1(b) (Ga. 2014) (The
purpose of the registry shall be to assist in the development of public policy
and planning relative to Alzheimers disease and related disorders. The
registry shall provide a central data base of individuals with Alzheimers
disease or related disorders.).
207. SUMMARY OF THE HIPAA PRIVACY RULE, supra note 205, at 2; see also
45 C.F.R. § 160.10203 (2015) (listing what entities HIPPA applies to and the
definition of covered entities).
208. See U.S. DEPT OF HEALTH AND HUMAN SERVS., PROTECTING
PERSONAL HEALTH INFORMATION IN RESEARCH: UNDERSTANDING THE HIPAA
PRIVACY RULE 5 (2003) [hereinafter UNDERSTANDING THE HIPAA PRIVACY
RULE],
http://privacyruleandresearch.nih.gov/pdf/HIPAA_Privacy_Rul
e_Booklet.pdf. A health plan is defined as an individual or group plan that
provides or pays the cost of medical care. Id. at 25. While this includes some
government programs, neither the Georgia Registry nor the Task Force that
run it provide or pay for any medical care. A health care clearinghouse
includes public and private entities that provide billing services, repricing,
health information management services, and value-added networks that
process health information for other entities. Id. The Registry does not provide
any such services. Finally, health care provider refers to a provider of medical
or health services . . . and any other person or organization who furnishes,
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A health plan is defined as an individual or group plan
that provides or pays the cost of medical care.209 While this
includes some government programs, neither the Georgia
Registry nor the Task Force that runs it provides or pays for
any medical care.210 A health care clearinghouse includes
public and private entities that provide billing services,
repricing, health information management services, and
value-added networks that process health information for
other entities.211 The Registry does not provide any such
services.212 Finally, health care provider refers to a provider of
medical or health services . . . and any other person or
organization who furnishes, bills, or is paid for health care in
the normal course of business.213 The Registry does not
perform this service either.214 Although the Registry does not
constitute a covered entity, we nevertheless suggest that, in
order to ensure compliance with the constitutional right to
privacy in Georgia and general best practices for patient
confidentiality, the Registry adhere to the HIPAA standards for
covered entities.
The first step in any HIPAA analysis is to understand the
definition of protected health information (PHI). PHI refers to
individually identifiable health information.215 Thus, de-

bills, or is paid for health care in the normal course of business. Id. The
Registry does not perform this service either.
209. Id.
210. See H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014).
211. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at
25.
212. See H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014).
213. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at
25.
214. See H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014).
215. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at 8.
According to the Privacy Rule, PHI also only encompasses such information
created or maintained by a covered entity or its business associates acting for
the covered entity. Id. However, for the purposes of this article, we will define
it to include personally identifiable health information held by the Georgia
Registry. The Privacy Rule defines de-identified health information as
information from which the following have been removed:
1. Names.
2. All geographic subdivisions smaller than a state . . . except for
the initial three digits of a ZIP code[, assuming that there are at least
20,000 people who share those digits].
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identified data relating to Alzheimers rate will not be subject
to the restrictions described in the following paragraphs. PHI
may always be disclosed with the patients written consent in
the form of an authorization.216 An authorization must be
written in plain language, and it must specifically describe (1)
the information to be disclosed; (2) the person disclosing the
information; (3) the person receiving the information; (4) the
authorization expiration; and (5) the right to revoke the
authorization in writing.217 Examples of disclosures requiring
such authorizations include disclosures to life insurance
companies, patients employers, or pharmaceutical firms.218
The HIPAA Privacy Rule recognizes that sometimes PHI is
required for research and that obtaining authorization for all

3. All elements of dates (except year) for dates directly related to an
individual, including birth date, admission date, discharge date, and
date of death; and all ages over 89 and all elements of . . . such age,
except . . . [to] aggregate[ them] into a single category of 90 or older.
4. Telephone numbers.
5. Facsimile numbers.
6. Electronic mail addresses.
7. Social security numbers.
8. Medical record numbers.
9. Health plan beneficiary numbers.
10. Account numbers.
11. Certificate/license numbers.
12. Vehicle identifiers and serial numbers, including license plate
numbers.
13. Device identifiers and serial numbers.
14. Web universal resource locators (URLs).
15. Internet protocol (IP) address numbers.
16. Biometric identifiers, including fingerprints and voiceprints.
17. Full-face . . . [pictures] and any comparable images.
18. Any other unique identifying number, characteristic, or code,
unless otherwise permitted by the Privacy Rule.
Id. at 10. Alternatively, accepted statistical methods may be used to deidentify data. Id.
216. Id. at 9, 1112. For more information on the specific requirements of
an Authorization, see pp. 1112 of SUMMARY OF THE HIPAA PRIVACY RULE,
supra note 205.
217. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at
12.
218. SUMMARY OF THE HIPAA PRIVACY RULE, supra note 205, at 9.
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data sought may not be practicable.219 For that reason, it
contains an alternative provision for obtaining a waiver, or
alteration of authorization.220 The waiver or alteration must be
approved by an Institutional Review Board (IRB) or a Privacy
Board.221 IRBs were created in the 1960s to ensure the ethical
treatment of human subjects of clinical research.222 They
remain responsible for ensuring that informed consent has
been given and documented pursuant to the U.S. Department
of Health and Human Services (HHS) and U.S. Food and Drug
Administration (FDA) Protection of Human Subjects
Regulations (HHS and FDA Regulations).223 Privacy Boards
were authorized by the HIPAA Privacy Rule as alternative
review boards for waiver or alteration of authorization
requests.224 Both boards must adhere to strict guidelines
regarding composition and procedure.225
Pursuant to the HHS and FDA Regulations, each IRB
must have at least five members with varying
backgrounds.226 Specifically, a Board must meet the following
requirements:
The IRB must be sufficiently qualified through the experience and
expertise of its members, and the diversity of members, including
consideration of race, gender, and cultural backgrounds and
sensitivity to such issues as community attitudes, to promote respect

219. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at
13 ([I]t may not be feasible for a researcher to obtain a signed Authorization
for all PHI the researcher needs to obtain for the research study.).
220. Id; see also 45 C.F.R. § 164.512 (2015) (discussing the uses and
disclosures for which an authorization or opportunity to agree or object is not
required).
221. UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at 13
([T]he Privacy Rule contains criteria for waiver or alterations of
Authorizations by an IRB or another review body called a Privacy Board.).
222. See WILLIAM H. SCHNEIDER, THE ESTABLISHMENT OF INSTITUTIONAL
REVIEW
BOARDS
IN
THE
U.S.
BACKGROUND
HISTORY,
http://www.iupui.edu/~histwhs/G504.dir/irbhist.html (last visited Sept. 6,
2015).
223. See UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at
11.
224. Id. at 13.
225. See generally U.S. DEPT OF HEALTH & HUMAN SERVS.: NATL INSTS.
OF HEALTH, PRIVACY BOARDS AND THE HIPAA PRIVACY RULE 1 (2004)
[hereinafter HIPAA PRIVACY BOARDS], https://privacyruleandresearch.nih.gov
/pdf/privacy_boards_hipaa_privacy_rule.pdf.
226. Id. at 6 (offering a comparison of IRBs and Privacy Boards in the
Frequently Asked Questions section).
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for its advice and counsel in safeguarding the rights and welfare of
human subjects.227

The Board must have members from different professions (at
least one scientific and one non-scientific) with the capability to
analyze proposed research with regard to applicable
regulations, laws, and standards of professional conduct and
practice.228 Finally, at least one member must be independent
from the institution, and any member with a conflicting
interest in a decision must recuse himself.229
Privacy Boards were created to supplement the IRBs.230
Like IRBs, Privacy Boards must have members with diverse
backgrounds and professional competencies.231 At least one
member must not have any association with the covered entity
or the researcher, and members must recuse themselves where
conflicts of interest arise.232
The procedural rules for both IRBs and Privacy Boards are
the same.233 In order to receive a waiver or alteration of the
requisite authorization to access PHI, a researcher must
demonstrate that the research could not be completed
practicably without use of the PHI, and the PHI could not
practicably be accessed without the waiver or alteration.234 In
addition, the researcher must demonstrate that the patient
privacy risk is minimal because there is an adequate plan to

227. Id.
228. Id.
229. Id.; see also US DEPT OF HEALTH AND HUMAN SERVS.: NATIONAL INST.
OF HEALTH, INSTITUTIONAL REVIEW BOARDS AND THE HIPAA PRIVACY RULE 5
(2003) [hereinafter HIPAA IRBS], http://privacyruleandresearch.nih.gov
/irbandprivacyrule.asp (presenting a similar rule for Institutional Review
Boards).
230. See HIPAA PRIVACY BOARDS, supra note 225, at 1 (explaining that
authorization can be obtained by an Institutional Review Board or a new type
of review body, a Privacy Board).
231. See id. at 6.
232. Id.
233. Compare HIPAA PRIVACY BOARDS, supra note 225, at 34 (describing
Privacy Board approval proceedings), with HIPAA IRBS, supra note 229, at 4
5 (describing IRB review proceedings). HHS has recently issued proposed
rules modifying a number of IRB operations and requirements, as governed by
the Common Rule, including potentially significant changes to the rules for
exempt research, expedited review, and waivers of consent. See Federal Policy
for the Protection of Human Subjects, 80 Fed. Reg. 53,933 (proposed Sept. 8,
2015) (to be codified at 45 C.F.R. pt. 46).
234. See, e.g., HIPAA IRBS, supra note 229, at 4.
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protect the PHI identifiers from improper disclosure or use.235
Moreover, unless there is a health or research justification for
keeping the identifiers, the identifiers will be destroyed at the
earliest possible time, unless otherwise required by law.236
Finally, the researcher must provide a written statement that
he will not reuse the PHI or disclose it except for permissible
oversight of his study, for other studies in which use of the
information is authorized, or as required by law.237
Some Alzheimers patients may not object to having their
personal information disclosed. When they provide information
to the Registry (or to individuals required to submit it to the
Registry), they should be given the option of signing an
authorization to disclose their information to researchers. Some
patients may be less protective of their information and elect to
choose this option in order to promote Alzheimers research.
However, if researchers would like PHI of those who elect not
to authorize its release, we recommend that they be required to
obtain a waiver or alteration of authorization from an IRB or
Privacy Board.
Our analysis of HIPAA would not be complete if we did not
consider potential repercussions to covered entities, such as
hospitals, that may be asked to provide data to the Registry.
Such healthcare providers may cite HIPAA and claim that they
would run afoul of federal law if they provide information to
the Registry without patient consent. As analyzed above,
however, we conclude that the Registry constitutes a public
health authority, and the HIPAA Regulations permit the
disclosure of personally identifiable information to public
health authorities for disease surveillance, disease prevention,
and other public health purposes, such as reporting disease and
injury.238 HIPAA also permits public health authorities to
collect information for public health purposes and to enter this
information into their own databases without authorization.239
HIPAA defines a public health authority as:

235. Id.
236. Id.
237. Id.
238. See generally, 45 C.F.R. § 164.512 (2015) (listing an exception for
public health authorities).
239. See id. (enumerating standards for various entities which are subject
to these exclusions).
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[A]n agency or authority of the United States, a State, a territory, a
political subdivision of a State or territory, or an Indian tribe, or a
person or entity acting under a grant of authority from or contract
with such public agency . . . that is responsible for public health
matters as part of its official mandate.240

The Registry is acting under a grant of authority from the
State of Georgia, and it is responsible for public health matters
as part of its official mandate.241 Accordingly, hospitals and
other health care providers reporting data to the Registry
should not be concerned about HIPAA liability.
D. PRIVACY RISKS DESPITE STATUTORY
CONFIDENTIALITY REQUIREMENT
Despite federal and state constitutional and statutory
protections, it is reasonable for Georgians to fear disclosure of
personal information reported to the Registry. Alzheimers
disease is an expensive and debilitating disease to which public
misconceptions still attach.242 People suffering from
Alzheimers often face violations of their human rights, abuse
and neglect, as well as widespread discrimination.243 As their
autonomy decreases, Alzheimers and dementia patients may
simultaneously face loss of their political, civil, economic,
social, and cultural rights.244 Discrimination against these
patients is often the result of a fear that reduced mental
capability poses a safety risk to others.245
There are a number of ways that personal data may be
intentionally or inadvertently disclosed. Confidentiality
requirements in Georgia House Bill 966 highly restrict the

240. See 45 C.F.R. § 164.501 (2015).
241. GA. CODE ANN. § 31-2A-17(b) (2015) (The purpose of the registry shall
be to assist in the development of public policy and planning. (emphasis
added)).
242. See Equality, Discrimination and Human Rights, ALZHEIMERS SOCY,
http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=1
674 (last visited Sept. 13, 2015) (There remains significant misunderstanding
about and stigma attached to dementia that manifests itself in widespread
discriminatory attitudes.).
243. Id.
244. See id.
245. See NICOLE L. BATSCH & MARY S. MITTELMAN, WORLD ALZHEIMERS
REPORT 2012: OVERCOMING THE STIGMA OF DEMENTIA 9 (2012)
http://www.alz.org/documents_custom/world_report_2012_final.pdf.
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disclosure of Registry data.246 Bill 966 states, in no uncertain
terms, that the collected data in the Registry shall be
confidential and that all persons to whom the data is released
shall maintain patient confidentiality.247 The Bill does,
however, explicitly allow for disclosure of medical information
for use in scientific and medical studies.248 Accordingly,
patients understandably may be concerned with such potential
secondary uses of medical information in the Registry, even
though the enabling statute of the Registry specifically
prescribes that no publication of information, biotechnical
research, or medical data shall be made that identifies any
patient by name.249
In addition to the authorized disclosures in House Bill 966,
Georgia law otherwise may allow disclosure of medical records
as part of criminal or other enforcement proceedings.250
Registry data also may inadvertently be disclosed to
unauthorized
individuals
and
potentially
used
for
discriminatory or otherwise wrongful purposes.251 Also, because
all of the data in the Registry will be transferred and stored
electronically, the state must guard against hackers who may
break into the registration system.252 Pharmaceutical
companies, in particular, would find the information beneficial
in their research and marketing efforts.253 Keeping electronic

246. See GA. CODE ANN. § 31-2A-17(d) (2015) (requiring Registry
compliance with HIPAA regulations).
247. See id.
248. See id.
249. Id.
250. See, e.g., King II, 577 S.E.2d 764, at 766 (upholding a procedurally
valid subpoena against charge of unconstitutional invasion of privacy).
251. See generally U.S. DEPT OF EDUC., PRIVACY & TECH. ASSISTANCE
CTR., FREQUENTLY ASKED QUESTIONSDISCLOSURE AVOIDANCE 2 (2013),
http://ptac.ed.gov/sites/default/files/FAQs_disclosure_avoidance.pdf (Since the
release of any data carries at least some element of risk, it may not [be]
possible to entirely eliminate the risk of accidental data disclosure.).
252. See, e.g., John Leyden, Brit Charged With Hacking Pentagon, NASA,
THE REGISTER, (Nov. 13, 2002), http://www.theregister.co.uk/2002/11
/13/brit_charged_with_hacking_pentagon/.
253. See Jamie Cattell et al., How Big Data Can Revolutionize
&
COMPANY
(Apr.
2013),
Pharmaceutical
R&D,
MCKINSEY
http://www.mckinsey.com/insights/health_systems_and_services/how_big_data
_can_revolutionize_pharmaceutical_r_and_d (describing how the use of bigdata can help pharmaceutical companies better identify new potential drug
candidates).
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data secure is a challenge even for government agencies
guarding top-secret information.254
Finally, even de-identified data may include other
characteristics, such as race, age or occupation, of interest to
researchers;255 therefore, disclosure of such data could have the
tendency to create harmful presumptions about the capabilities
of Alzheimers disease patients.256 The potential conclusions of
such research studies could lead the public to believe that
certain characteristics are always indicative of Alzheimers
disease, which could then lead to discrimination.257 While that
sort of aggregate data created by the Registry could lead to
important medical findings and facilitate policy planning,
public health officials must weigh potential benefits against the
possibility that aggregate data can produce unintended
consequences to Alzheimers disease patients.
E. ADVERSE EFFECT ON PHYSICIAN-PATIENT
RELATIONSHIP
In addition to the privacy concerns with the Registry
discussed above, we wish to flag particular issues affecting the
physician-patient relationship. The confidentiality provisions
that protect Alzheimers patients do not apply to physicians.258
In particular, nothing in House Bill 966 prevents the
information in the Registry from being used to generate
aggregate data about individual physicians patient
populations.259 Such data may be of interest to insurance
companies and potential medical malpractice litigants.260 In

254. Leyden, supra note 252.
255. For the specifics requirements of de-identification under the HIPAA
Privacy Rule, see supra text accompanying note 215.
256. See Krent et al., supra note 82, at 23 (noting similar risks for diabetics
under an analogous New York registry).
257. Id.
258. Cf. GA. CODE ANN. § 31-2A-17(d) (2015) ([A]nd all persons to whom
the data is released shall maintain patient confidentiality. (emphasis added)).
259. See H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014) (establishing
that the bill does not address the physician data).
260. See generally PETER GROVES ET AL., THE BIG DATA REVOLUTION IN
HEALTHCARE: ACCELERATING VALUE AND INNOVATION 1 (2013),
https://www.mckinsey.com/~/media/mckinsey/dotcom/client_service/Healthcar
e%20Systems%20and%20Services/PDFs/The_big_data_revolution_in_healthca
re.ashx (stating that many private sector companies are using available
healthcare data to build[] applications and analytical tools that help patients,
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both cases, availability of physician demographics via the
Registry could create incentives for doctors to over- or underdiagnose Alzheimers disease. On one hand, insurers might be
reluctant to include a physician with a high caseload of
Alzheimers and related dementia patients in their networks.261
On the other hand, physicians paid on a capitated basis, may
be tempted to over-diagnose to ensure that they receive
adequate reimbursement.262
With respect to litigation risks, under- or over-diagnosis
could erode patients trust in the physicians and impair the
physician-patient relationship. For example, if a physician
over-reports the number of Alzheimers patients whom he
treats, that may inaccurately signal to the public that he has
substantial experience or expertise in dealing with such
patients. Reasonable reliance on such a misrepresentation
could form the basis for a medical malpractice action.263 Even
more importantly, from the perspective of professional ethics, if
the Registry requires doctors and hospitals to either report or
allow government inspection of patient data, such disclosures,
even if permitted by HIPAA and other privacy laws, could still
compromise the consent and confidentiality requirements of the

physicians, and other healthcare stakeholders identify value and
opportunities).
261. Mistreating Alzheimers could result in malpractice suits. See On
Alert: What All Doctors Need to Know About Alzheimers Disease,
http://www.thedoctors.com
THEDOCTORSCOMPANY,
/KnowledgeCenter/PatientSafety/articles/On-Alert-What-All-Doctors-Need-toKnow-About-Alzheimers-Disease (last visited Oct. 7, 2015) (Physicians of all
specialties should become familiar with the early signs of this disease
[Alzheimers] in order to refer patients with symptoms to a specialist for
further testing.).
262. See Patrick C. Alguire, Understanding Capitation, AM. COLL. OF
PHYSICIANS,
https://www.acponline.org/residents_fellows/career_counseling/understandcapi
t.htm (last visited Oct. 6, 2015), for background on how capitation payments
work and how it can shift physician incentives.
263. While negligence is by far the most common medical malpractice
cause of action, other causes of action that may be asserted include . . .
misrepresentation (fraud). Joe R. McFarlane Jr. & Paul Weber, What is
MUTUAL
INS.
C O.
(1993),
Medical
Malpractice?,
OPHTHALMIC
http://www.omic.com/what-is-medical-malpractice/. In Georgia, [c]onstructive
fraud consists of any act of omission or commission, contrary to legal or
equitable duty, trust, or confidence justly reposed, which is contrary to good
conscience and operates to the injury of another. GA. CODE ANN. § 23-2-51(a)
(2015).
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Hippocratic ethic.264 This could lead patients to be less
forthcoming with medical professionals out of concern that
their personal information will be disseminated without their
consent.265 Chilling patients candor would negatively impact
their treatment266 and, again, invite potential medical
malpractice liability for physicians who would be operating
without full information.267
IV. PROCEDURAL RULES
The enabling statute of Georgia Registry, namely House
Bill 966, closely tracks the enabling statute of the West
Virginia Registry. Both statutes explicitly call for promulgation
of procedural rules by the institution designated to administer
the registry.268 The West Virginia Procedural Rules were
written in consultation with the West Virginia University
Associate Counsel and the Counsel to West Virginia Senate
Health and Human Services Committee.269 Additionally, the
West Virginia Procedural Rules were promulgated through
formal notice and comment rulemaking and took effect on
December 27, 2007.270 They established procedures governing
the registry including purpose, content, data management,
confidentiality, security and protection, and establishment of
an advisory board.271

264. See Jessica De Bord et al., Confidentiality, UNIV. OF WA. SCH. OF MED
(2013), http://depts.washington.edu/bioethx/topics/confiden.html (discussing
the importance of confidentiality in the physician-patient relationship).
265. See id. (discussing how, if patient confidentiality is breached,
[p]atients would be less likely to share sensitive information, which could
negatively impact their care.).
266. See id.
267. See sources cited and discussion supra note 263.
268. Compare H.R. 966, 152d Gen. Assemb., Reg. Sess. (Ga. 2014) (The
department shall establish procedures and promulgate rules and regulations
for the establishment and operation of the registry), with W. VA. CODE §16-5R
(2015) ([T]he governing board shall propose rules pursuant to the provisions
of article three, chapter twenty-nine-a of this code to implement this section.).
269. See West Virginia Alzheimers Disease Registry: Registry History,
supra note 86.
270. W. VA. CODE R. § 64-94-1, subsec. 1.11.4 (2015) (specifying that the
West Virginia Administrative Procedures Act is applicable to procedural rules
for the West Virginia Alzheimers Disease Registry); W. VA. CODE R. § 29A-3-5
(2015) (requiring notice be provided for proposed rules).
271. W. VA. CODE R. §§ 64-24-1 to -13 (2015).
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Similarly, House Bill 966 mandates that the Georgia DPH
shall establish procedures and promulgate rules and
regulations for the establishment and operation of the Registry,
which shall provide for:
1. Collecting and evaluating data regarding the prevalence of
Alzheimers disease and related disorders in Georgia, including who
shall report the data to the registry;
2. Determining what information shall be maintained in the
registry and the length of time such data shall be available;
3. Sharing of data for policy planning purposes;
4. Disclosing non-identifying data to support Alzheimers and
related disorder research;
5. [Determining t]he methodology by which families and physicians
of persons who are reported to the registry shall be contacted to
gather additional data; and
6. [Gathering and providing i]nformation about public and private
resources.272

In anticipation of the official release of the procedural rules
for the Georgia Registry (Procedural Rules), it is helpful to
review the West Virginia Procedural Rules for guidance and
consider options the Procedural Rules may present to make
improvements tailored to the situation of Georgia. We find
many features of the West Virginia instructive but also suggest
additional considerations and improvements.
A. MANDATORY AND PERMISSIVE REPORTERS
The West Virginia Procedural Rules mandate that
healthcare providers and facilities report cases of Alzheimers
disease that they diagnose or treat.273 Similarly, the Georgia
Procedural Rules should define the range of data reporters as
broadly as possible, as suggested by the June 2014
Stakeholders Conference findings above.274 Based on those
recommendations, the list of reporters can be quite
extensive,275 and the rules could specify some reporters as
permissive and others as mandatory. The rules also should
include a detailed definition section to make sure the reporting
272. H.R. 966, 152d Gen. Assemb., Reg. Sess. § 1(c)(1)(6) (Ga. 2014); see
also GA. CODE ANN. § 31-2A-17(c)(1)(6) (2015).
273. W. VA. CODE R. § 64-94-8 (2015) (Health care Providers and
Facilities . . . shall provide a report of each case of the disease or condition as
required by this rule.).
274. Sponsored Stakeholders Meeting Memorandum, supra note 3, at 2.
275. See id.
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duties on various institutions and individuals are
unambiguous. For example, if health care providers were
required to report, the Georgia Procedural Rules would need to
be clear on who is considered to be a health care provider.276
Similarly, if a patients legal representatives could provide
written disclosure authorization for other people to get access
to the patients confidential information, the Georgia
Procedural Rules also would need to be clear on who are legal
representatives of a patient in Georgia.277
The Registry should begin by building on Georgias Online
Analytical Statistical Information System (OASIS), a
nationally regarded public health data collection system, with
any additional collection efforts linked to OASIS.278 Moreover,
OASIS has the following benefits:
[It]s an important starting place for the collection and evaluation of
additional data required for improved prevalence estimates. For
example, measuring prevalence of dementia requires reliable
denominators (persons at risk). The denominator data in OASIS are
clean and accountable. The challenge is estimating the strategy and
accuracy of the numerators (cases).279

Since one of the long-term goals for the Registry is to develop
the capacity of capturing disease incidence, OASIS, given its
ability to provide accurate denominators, is a great starting
place in achieving that objective.280
B. DATA CONTENT AND RETENTION
To ensure that the data collected is robust enough to aid
future policy planning, the West Virginia Procedural Rules
specify that the West Virginia Registry collect not only
minimum information necessary to maintain the registry but
also the most relevant and complete summary statistics and
276. Cf. UNDERSTANDING THE HIPAA PRIVACY RULE, supra note 208, at 25
(giving the definition of a health care provider under HIPPA).
277. See generally id. at 2427 (providing a list of defined terms useful in
correctly interpreting HIPAA rules).
278. Conference Summary, Univ. of Ga. Inst. of Gerontology, Moving the
Georgia Alzheimers Disease Registry Forward: Commentary for the
Stakeholders Meeting (May 22, 2014) [hereinafter Commentary for the
Stakeholders Meeting] (on file with author); Online Analytical Statistical
Information System (OASIS), GA. DEPT OF PUB. HEALTH: OFFICE OF HEALTH
INDICATORS FOR PLANNING, https://oasis.state.ga.us/What-Can-Oasis-Do-ForYou.aspx (last visited Oct. 6, 2015).
279. Commentary for the Stakeholders Meeting, supra note 278, at 1.
280. Id.
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information required to advise policy development.281 Under
the West Virginia Procedural Rules, data collected include:
a. Last name, first name and middle initial;
b. Birth date;
c. Gender;
d. Last four digits of the Social security number;
e. Maiden name (if female),
f. Race/ethnicity;
g. Address, including street, city, county, and zip code;
h. Contact information, including secondary contacts;
i. Brief medical history;
j. History of Alzheimers disease and related disorders;
k. Physicians name;
l. Physicians contact information including address, phone, fax
numbers, or email; and
m. Other information considered relevant for policy and planning
relative to Alzheimers disease and related disorders.282

The West Virginia Procedural Rules, however, do not specify
the length of time data should remain available.283
In addition to the data collected in West Virginia, our
Stakeholder Conference suggested that the Georgia Registry
collect additional information, including:
1. [P]rimary language;
2. Healthcare utilization history;
3. Community resources used by the individual;
4. Living arrangements, i.e., who else is present in the home;
5. Associated health conditions plus [any special] need for assistive
technology like dialysis, oxygen, etc.;
6. Licenses held by the person with dementia: driving, boats,
firearms, [and] other professional.284

On the other hand, we recommend that the Registry exclude
physicians name and physicians contact information from the
publicly available database of the Registry due to the concern
that the registry will harm the physician-patient
281. See W. VA. CODE R. § 64-94-4, subsec. 4.2 (2015) (The content and
design of all forms for the Registry shall be consistent with the minimum
information necessary to maintain the registry . . . .). Similar language
appears in W. VA. CODE R. § 64-94-4, subsec. 4.3 (2015) (discussing [t]he
content and design of reports).
282. W. VA. CODE R. § 64-94-4, subsec. 4.1.a.m. (2015).
283. See id. (providing a comprehensive list of [i]nformation to be
reported).
284. Sponsored Stakeholders Meeting Memorandum, supra note 3, at 2.
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relationship.285 Physicians names and contact information
should only be disclosed for notification purposes, or,
alternatively, they should be maintained separately from the
publicly available database. Requiring physicians to reveal
patient information could harm the physician-patient
relationship, but mere inclusion of the physicians name in the
Registry would not seem to have that effect.286
In addition to collecting enough information to build up a
comprehensive database, the Registry also needs to maximize
safeguards for data security. We recognize that full
implementation of data security will take time to achieve.287 At
the outset, we advocate that the Registry prioritize public
health objectives, organizing any collected data without
individual identifiers. For example, issues like healthcare
workforce, public safety, transportation, and housing can be
emphasized. Public health policy-driven questions, such as
correlating the impact of dementia on hospital lengths of stay,
could be studied. Answers to such questions are critical for
hospital strategic planning and cost containment.288 Yet the
research does not require identification of specific patients.289
Finally, we would improve upon the West Virginia
Procedural Rules by prescribing the length of time that the
data will be available, so that obsolete or duplicated data can
be identified, updated, or deleted if necessary.290 Clear data
retention periods would alleviate the burden on reporters and

285. See De Bord et al., supra note 264 (discussing the importance of
confidentiality in the physician-patient relationship).
286. See id.
287. See LEE A. KADEL, DESIGNING AND IMPLEMENTING AN EFFECTIVE
INFORMATION SECURITY PROGRAM: PROTECTING THE DATA ASSETS OF
INDIVIDUALS,
SMALL
AND
LARGE
BUSINESSES
ii
(2004),
https://www.sans.org/reading-room/whitepapers/hsoffice/designingimplementing-effective-information-security-program-protecting-data-assetsof-1398 (The need for information security should be apparent, but . . . an
effective security program requires substantial research, and often a great
investment of time and resources.).
288. See Mike Miliard, 6 Ways Big Data Can Lower Costs, HEALTHCARE IT
NEWS (July 10, 2014), http://www.healthcareitnews.com/news/6-ways-bigdata-can-lower-costs.
289. See id.
290. See W. VA. CODE R. §§ 64-94-1 to -13 (2015) (illustrating that the West
Virginia Procedure Rules have no provision for disposing of Alzheimers data).
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reduce the possibility of inadvertent disclosure of antiquated,
inactive data sources.291
C. DATA SHARING
With attention to the privacy concerns under federal and
state law discussed above, we recommend slightly broader data
sharing with the Georgia Registry than authorized in West
Virginia. The West Virginia Procedural Rules limit disclosure
of de-identified information for research purposes only.292
Otherwise, the West Virginia Registry may disclose
confidential information regarding a patient with Alzheimers
disease only to:
a. The individual [patient];
b. The individuals [legal] representative;
c.
A physician or other health care provider . . . for the purpose of a
medical evaluation or treatment of the individual;
d. Any individual or entity which provides the Registry with a
lawful written authorization for the disclosure of confidential
information from the individual [patient] . . . or that individuals
[legal] representative; or
e. Any individual or entity which provides the Registry with an
order from a court of competent jurisdiction ordering the disclosure of
confidential information.293

The West Virginia Procedural Rules, while recognizing the
policy-planning goal of the West Virginia Registry, appear to
restrict disclosure for research purposes only.294 We
recommend that Georgias procedural rules expressly recognize
policy planning as a purpose of disclosure while remaining
cautious not to undermine confidentiality. De-identified
information should be clearly available to policymakers,
including local and county governments, to enable officials to
enact policies responsive to any increased prevalence of
Alzheimers patients in their areas.295 Each of Georgias
counties has a unique experience with dementia and its impact
291. See generally INFO. COMMNS OFFICE, THE GUIDE TO DATA
PROTECTION 37 (2015), https://ico.org.uk/media/for-organisations/guide-todata-protection-2-2.pdf (describing the risks of retaining personal data for long
periods).
292. W. VA. CODE R. § 64-94-10, subsec. 10.2.1 (2015) (The Registry may
disclose non-identifying information for research purposes only.).
293. Id. subsec. 10.3.1.
294. See id.
295. See Commentary for the Stakeholders Meeting, supra note 278, at 2.
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on residents and local institutions[; r]ural communities needs
differ from urban communities.296 A more transparent and
liberal data-sharing process than West Virginias will promote
the needed responsiveness and innovation required to meet the
challenge of [Alzheimers disease and] dementia.297
Moreover, we contemplate a role for public policy, public
health, gerontology, and other research institutes and thinktanks. Based on the positions of our current stakeholders, we
anticipate that the following organizations will have strong
interest in the Registry:
a. The National Institute on Aging
b. [The] National Institutes of Health
c.
The Public Health Law Program in the Office for State, Tribal,
Local and Territorial Support (OSTLTS) at the Centers for Disease
Control [and Prevention]
d. The Robert Wood Johnson Foundation
e. [The] Public Health Law Program
f.
The Cooperative Extension Program
g. The Georgia Hospice and Palliative Care Organization
h. Patient Centered Outcomes Research Institute
i.
Centers for Medicare and Medicaid, Region IV298

Given the important role of such organizations, we recommend
that the Georgia Procedural Rules include provisions allowing
participation and assistance from these and similar
organizations and institutions.299 Moreover, Georgias
Procedural Rules should formalize and stabilize any existing
cooperation between the Registry and the various types of
organizations mentioned above.
Like West Virginia, we certainly support data sharing for
research purposes, and, as recommended above, would limit
such disclosures consistent with HIPAA requirements for
covered entities, even though we conclude that the Registry
technically is not a covered entity for HIPAA purposes.300

296. Id.
297. Id.
298. See id. at 3.
299. See id.
300. See W. Va. Alzheimers Disease Registry, supra note 118 and
accompanying text.
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V. BEST PRACTICE FOR ESTABLISHING THE REGISTRY
In light of the increasingly epidemic nature of Alzheimers
disease, the detrimental health effects on its sufferers, and the
financial burdens on the taxpayers, the Georgia Registry takes
an important step on the path toward better understanding
and management of Alzheimers disease in Georgia.301 The
information gathered by the Registry may help determine
which groups are most at risk, so that resources can be directed
to those groups. Information in the Registry also may further
current research regarding the overall effects of the disease.302
Gathering this wealth of information, however, also could
detrimentally affect patients, physicians, and other
stakeholders; therefore, we conclude by recommending best
practices of establishing and managing the Georgia Registry.
A. PRIVATE REGISTRIES AND STAKEHOLDER ADVISORY BOARD
Before the Georgia General Assembly passed legislation
establishing the Registry, many private institutions across the
country already had made tremendous efforts to establish their
own Alzheimers disease registries. For example, [t]he
Alzheimers Prevention Registry . . . , launched in October 2012
by the Banner Alzheimers Institute, is a new online
community of people who want to help scientists find
treatments to slow, halt, or prevent the memory-robbing
disorder.303 Private registries have attracted large groups of
people who personally participate in the combat against
Alzheimers disease and who are more likely to voluntarily
report to the Registry.304 Long established, private registries
also offer substantial registry management experience to share

301. See, e.g., 2014 ALZHEIMERS DISEASE: FACTS AND FIGURES, supra note
5, at 2122 (discussing the progression of Alzheimers disease within the
population from 2000 to 2050).
302. Cf. Population-Based Registries, supra note 4 (Cancer research
programs benefit greatly from the cancer data collected by population-based
cancer registries.).
303. See, e.g., Alzheimers Disease Educ. & Referral Ctr., New Alzheimers
Prevention Registry Recruiting 250,000 Volunteers, NATL INST. ON AGING
(Apr. 4, 2013), http://www.nia.nih.gov/alzheimers/features/new-alzheimersprevention-registry-recruiting-250000-volunteers.
304. See id. (Just six months after the registry was established, more than
9,300 members ha[d] already joined the effort.).
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with newcomers.305 Policymakers and others involved in
establishing the Registry would benefit from their assistance.
In the future, policymakers may also want to consider
creating a special advisory board for the Registry consisting of
diverse stakeholders in Georgia, including faculty from higher
education institutions (e.g. University of Georgia College of
Public Health), law enforcement officials (e.g. police officers),
and local non-profit institutions (e.g. the Archway Program).
The advisory board, which is not a feature of the West Virginia
Registry,306 would supervise the operation of the Registry and
monitor the authorization procedure to ensure the disclosure of
the Registry information or data to third parties is appropriate,
confidential, and legal. The expertise and experience of the
members of the advisory board with regard to medical data
management is necessary to the successful operation of the
Registry.307
B. DUAL DATA-SHARING PROCEDURE
In order to weigh the Georgia Registrys confidentiality
compliance against its designated function to collect and share
data for policy planning and research purposes, it is important
to distinguish aggregate data from personally identifiable
information. In statistics, aggregate data are data combined
from several measurements.308 When data are aggregated,
groups of observations are replaced with summary statistics
based on those observations.309 On the other hand, personally
identifiable information is any data that could potentially

305. See generally REGISTRIES FOR EVALUATING PATIENT OUTCOMES: A
USERS GUIDE ch. 2. (Gliklich RE, Dreyer NA, Leavy MB eds., 2014),
http://www.ncbi.nlm.nih.gov/books/NBK208631/ (showing the difficulty of
registry management); New Alzheimers Prevention Registry Recruiting
250,000 Volunteers, supra note 303 (explaining how private registries have
already gone through this process).
306. See W. VA. CODE § 16-5R-7 (2015) (establishing the Governing Board
of West Virginia University as the supervisor of the registry).
307. See Gliklich RE et al., supra note 305 (stating that experts are
necessary to establish a registry).
308. See, e.g., MARILYN SEASTROM, STATISTICAL METHODS FOR
PROTECTING PERSONALLY IDENTIFIABLE INFORMATION IN AGGREGATE
REPORTING
45
(2010),
http://nces.ed.gov/pubsearch
/pubsinfo.asp?pubid=2011603.
309. See id. at 4.
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identify a specific individual, either directly or by
implication.310
Since the Registry aims to provide information to
policymakers, aggregate data is more suitable to be presented
to the public.311 [A] regular newsletter to a list serve of
interested parties on specific registry related topics could be
an option for the Registry to share aggregate data.312 On the
other hand, disclosure of personally identifiable data should be
restricted to researchers and budget planners with a welldeveloped application process.313
The application process should be designed to protect data
that can identify an individual and potentially harm the
patient. The existing OASIS software and infrastructure can be
used, and a small application fee should be charged.314 We
recommend a data collection review board be established. The
application will be submitted to a data protection review board
(Board) established within the Registry. Through the detailed
application document, the Board will be supplied with the
information necessary to determine whether:
[T]he purpose of the request is consistent with the uses of the data
as defined by regulation, the applicant is qualified to undertake the
study, the proposed study/research is technically feasible, the
applicant needs all the data requested[,] and [the applicant] is able
to ensure that patient privacy is protected.315

This system of checks and balances, applied to all identifying
data requests, guards the rights of individuals while providing
access to needed registry information.
The dual data-sharing procedure, as we strongly suggest,
recognizes the need for data to be accessible so that there is a
more effective, efficient, and responsive registry. Basically, the
dual data-sharing procedure balances the need to know with
the need to protect the confidentiality of patient records. In all
cases, however, the Registry-specific data sharing procedures
310. See id.
311. Cf. id. (discussing the importance of protecting personal identifiable
information).
312. See Sponsored Stakeholders Meeting Memorandum, supra note 3, at
2.
313. Id.
314. See id.
315. N.Y. Dept of Health, Identifying Data Overview and Instructions,
(May
2013),
https://www.health.ny.gov
HEALTH.NY.GOV
/statistics/sparcs/dprb/overview.htm.
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should be consistent with HIPAA privacy standards under
federal law.316
C. STATE MEDICAID INCENTIVE PROGRAM AND OTHER
REWARDING MECHANISMS
We also envision opportunities through electronic health
records (EHR) to encourage reporting to the Registry. EHR is
being used nationwide317 to improve the quality, safety, and
efficiency of patient care.318 Under Georgias Medicaid
program, there is already a useful demonstration project
underway for incentivizing providers that utilize EHR in
meaningful ways.319
The [Georgia] Medicaid EHR Incentive Program is a voluntary,
multi-year, multi-stage program administered by the Georgia
Department of Community Health. [It] . . . is limited to eligible
Medicaid professionals for six years of participation, and eligible
Medicaid hospitals for three years as they adopt, implement,
upgrade or demonstrate meaningful use of certified EHR
technology.320

For those meeting all program requirements, eligible
professionals (excluding pediatricians) and eligible Medicaid
hospitals may receive various amounts of incentive payments
based on a number of factors, beginning with a base
payment.321
We suggest adopting a similar state incentive program for
Registry implementation. For example, if an eligible physician
or hospital provides information to the Registry in accordance
with the Procedural Rules, the physician may earn incentive

316. See U.S. DEPT OF HEALTH AND HUMAN SERVS.: OFFICE FOR CIVIL
RIGHTS, HIPAA ADMINISTRATIVE SIMPLIFICATION (Mar. 26, 2013),
http://www.hhs.gov/ocr/privacy/hipaa/administrative/combined/hipaasimplification-201303.pdf (detailing the HIPAA regulations).
317. Press Release, U.S. Dept of Health & Human Servs, More Physicians
and Hospitals are Using EHRs Than Before (Aug. 7, 2014),
http://www.hhs.gov/news/press/2014pres/08/20140807a.html ([A]lmost eight
in ten (78 percent) office-based physicians reported they adopted some type of
EHR system.).
318. Medicaid EHR Incentive Program, GA. DEPT OF CMTY. HEALTH,
http://dch.georgia.gov/medicaid-ehr-incentive-program (last visited Sept. 13,
2015).
319. See id. (Georgia is leading the way to incentivize providers that
utilize electronic health records . . . .).
320. Id.
321. Id.
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payments in the form of enhanced reimbursement.322 We
acknowledge that tying an incentive to Medicaid reaches only
the portion of the Alzheimers population that is Medicaideligible and that any call for additional payments would be
controversial under existing state budgetary challenges.323
Nevertheless, we wish to identify novel ways to ensure robust
data reporting to the Registry for maximum effectiveness.
D. MEDICAL-LEGAL PARTNERSHIP
We also perceive opportunities to support the Registry
through Georgias recent commitment to the medical-legal
partnership (MLP) model.
On April 21, 2014, Governor Nathan Deal signed SB 352, a bill
codifying MLPs in the state of Georgia. The new law gives Georgia
Department of Community Health authorization to approve medicallegal partnerships that comply with standards and guidelines for the
purpose of determining eligibility for grants. Georgia is the second
state after New York to endorse medical-legal partnerships and
create a process for certifying programs within the state.324

MLPs operate on the recognition that patients health care
needs may be amenable to not only medical, but also legal,
interventions.325 By including legal services providers on
patients overall treatment team, MLPs may identify and
address causes or contributors to poor health,326 such as stress
322. See generally Alan M. Scarrow, Physician Reimbursement Under
Medicare, MEDSCAPE MULTISPECIALITY (2002), http://www.medscape.com
/viewarticle/433293_print (explaining the physician reimbursement system
under Medicare).
323. See, e.g., Jim Galloway, Deal Rejects Expansion of Medicaid, ATL. J.CONSTITUTION (Aug. 28, 2012), http://www.ajc.com/news/news/state-regionalgovt-politics/deal-rejects-expansion-of-medicaid/nRMfK/ (citing the Georgia
state governors recent unwillingness to expand Medicare pursuant to the
Affordable Care Act due to budgetary concerns).
324. Georgia Second State to Endorse Medical-Legal Partnership, NATL
CTR FOR MED.-LEGAL PSHIP
(May
28,
2014),
http://medicallegalpartnership.org/georgia-becomes-second-state-endorse-medical-legalpartnership/.
325. See TISHRA BEESON ET AL., MAKING THE CASE FOR MEDICAL-LEGAL
PARTNERSHIPS: A REVIEW OF THE EVIDENCE 2 (2013), http://medicallegalpartnership.org/wp-content/uploads/2014/03/Medical-Legal-PartnershipLiterature-Review-February-2013.pdf.
326. See id. (implying that use of legal remedies to help patients where
both legal and medical implications arise may also help the patient with their
underlying medial issues, e.g. helping a patient obtain access to disability
benefits via a legal remedy will better prepare that patient to battle their
medical issues).
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and anxiety.327 Accordingly, MLPs may assist with a wide
range of legal needs that Alzheimers and related dementia
patients face, including estate planning, guardianship, advance
care planning, medical powers of attorney, public entitlements,
insurance, housing, and disability accommodations.328
Moreover, MLPs may represent patients in resolving Registryrelated legal matters, including privacy concerns with Registry
reporting, data sharing, and record retention.
E. DISPARATE REPORTING
To address the concern that Alzheimers disease unequally
burdens some populations, including racial and ethnic
minorities and people with intellectual disabilities,329 we
recommend the Registry be attuned to disparate reporting
methods. Disparate reporting means applying a different, but
reasonable, reporting mechanism to capture data on race, sex,
and disability as reported by different sources. Racial and
ethnic minorities are at greater risk for developing Alzheimers
disease and facing barriers to obtaining a diagnosis and
services after onset.330 In addition, because Alzheimers disease
primarily affects older adults, the population with youngeronset Alzheimers disease faces unique challenges with
diagnosis, care, and stigma.331 Ideally, the Registry will assist
researchers and policymakers to better understand the unique
challenges faced by these particular groups and create a plan

327. See generally HARVARD HEALTH PUBLNS, ANXIETY AND PHYSICAL
ILLNESS
(July
1,
2008),
http://www.health.harvard.edu/stayinghealthy/anxiety_and_physical_illness (discussing the link between anxiety
and physical illness).
ASSN,
328. Cf.
Challenges
You
May
Face,
ALZHEIMERS
http://www.alz.org/nca/in_my_community_22019.asp (last visited Oct. 8, 2015)
(describing common problems people with Alzheimers face); see also BEESON
ET AL., supra note 325 (listing generalized ways in which MLP services can
benefit all patients).
329. See Minorities Hardest Hit by Alzheimers, ALZHEIMERS ASSN, (July
21, 2004), http://www.alz.org/national/documents/minorities_english.pdf.
330. See Patoine, supra, note 51 (quoting Dr. Patrick A. Griffith, a
Professor of Clinical Medicine at the Morehouse School of Medicine: AfricanAmericans and Hispanics tend to come to the attention of physicians only in
the middle or later stages of the illness, . . . . [which] is a much more difficult
stage to treat.).
331. See Young/Early Onset Alzheimers & Dementia, ALZHEIMERS ASSN,
http://www.alz.org/alzheimers_disease_early_onset.asp (last visited Sept. 13,
2015).
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for improving Alzheimers disease reporting from these groups.
Lessons learned in this context may then be integrated with
the broader efforts to improve reporting for all people with
Alzheimers disease. Disparate reporting, which considers the
special needs of different interest groups, can be a viable
approach to close the reporting gap in Georgia.
F. EDUCATION AND OUTREACH
Despite the statutory and regulatory provisions allowing
for enforcement of reporting requirements, stakeholders agree
that a voluntary outreach and information-driven approach is
the most effective way to increase the number of people
participating in the Registry.332 Continuing Medical Education
presentations are a key method to reach physicians with
information about the Registrys reporting expectations.333
Public service announcements and other educational
campaigns about the existence, purpose, and value of the
Registry directed toward people with Alzheimers disease and
their families also may empower people with Alzheimers
disease and their families to report or encourage their
physicians to report.334
With the costs of providing care for patients with
Alzheimers approaching thirty billion annually in Georgia,
reporting to the Registry is a relatively low-cost tool to address
the problem.335 When paired with outreach to physicians,
patients, and families about the diagnosis and treatment of
Alzheimers disease, the Registry can assist in attacking the
encumbrance of Alzheimers disease in Georgia.

332. See Sponsored Stakeholders Meeting Memorandum, supra note 3, at
2 (listing a variety of ways in which the information should be distributed for
both policy planning and research, including the OASIS database and a
regular newsletter).
333. See SPRIDON S. MARINOPOULOUS ET AL., EFFECTIVENESS OF
CONTINUING
MEDICAL
EDUCATION
(2007),
http://archive.ahrq.gov
/downloads/pub/evidence/pdf/cme/cme.pdf (concluding that continuing medical
education is an effective method of updating medical professionals).
334. See generally New Alzheimers Prevention Registry Recruiting 250,000
Volunteers, supra note 303 (illustrating how private registries use public
outreach to encourage reporting).
335. See supra note 30 and accompanying text.
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VI. CONCLUSION
This article offers a unique window into one states
experience establishing an Alzheimers disease and related
dementia registry. Georgia is the most recent of a handful of
states to adopt such a registry and, in doing so, has already
committed to robust data collection practices along with a clear
commitment to protecting patients privacy. The authors were
privileged to convene a group of stakeholders to brainstorm and
submit rulemaking comments on Registry implementation to
the Georgia Department of Public Health. In addition, through
further consultation with state leaders in gerontology and
building on our own health law, public health, and legal
services expertise, we offer additional recommended best
practices for the Registry. We anticipate that Georgia is leading
a nationwide trend in addressing the rapidly rising incidence of
Alzheimers disease and related dementia with the aging
population. Accordingly, our recommendations will be valuable
not only for Georgia, but also for other states that may decide
to establish similar Alzheimers registries.

